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The most common way people give up their power  
is by thinking they don’t have any. 
Alice Walker 
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ABSTRACT 
 
Epithelial to mesenchymal transition (EMT) is a biologic process that allows a polarized epithelial 
cell to undergo biochemical changes that enable it to assume a mesenchymal cell phenotype. 
Therefore, EMT has been associated with a concomitant decrease of epithelial markers (e.g. E-
cadherin) and increase of mesenchymal markers (e.g. Vimentin and α-SMA), as well as enhanced 
migratory and invasion capacity, resistance to apoptosis and increased production of 
extracellular matrix (ECM) components. EMT-cells may undergo a reverse process, 
mesenchymal to epithelial transition (MET), through which they are able to recover the 
epithelial phenotype. In some cases, EMT reversion may not be fully accomplished, giving rise 
to a metastable phenotype characterized by a simultaneous expression of epithelial and 
mesenchymal features. EMT has been shown to occur both under physiological settings, namely 
embryogenesis and wound healing, and in pathological situations, such as fibrosis. Several 
reports suggested that EMT/MET may also have a role during cancer progression and metastasis 
establishment. To elucidate this hypothesis, different EMT models have been implemented 
using traditional two-dimensional (2D) systems. However, such models lack the influence of a 
proper three-dimensional (3D) ECM-like structure that could better mimic the in vivo 
microenvironment, a major regulator of the EMT/MET program. Therefore, improved in vitro 
systems that better mimic the tumour microenvironment are needed in order to closely 
reproduce the EMT transcriptional program that occurs in vivo. 
The central aim of this Master Thesis was the establishment of a 3D in vitro model of TGF-β1-
driven EMT/MET induction in EpH4 epithelial cells cultured on an artificial alginate-based matrix 
with tuneable properties. In addition, we aimed to further characterize the 2D in vitro model of 
TGF-β1-driven EMT/MET induction previously established in the group, by assessing the 
stemness features of the EpH4 cells in different stages of the process, as well as their ability to 
produce matrix metalloproteinases (MMPs).  
Our results demonstrated that the 2D EMT-derived cells have enhanced stem-like features 
(resulting from the enrichment in a CD29+/CD44+ subpopulation) and produce increased levels 
of MMP9. Regarding the 3D EMT/MET model, our findings showed a TGF-β1-mediated EMT 
program characterized by E-cadherin impairment and increased mesenchymal markers, both at 
RNA and protein level (e.g. Vimentin and α-SMA). Moreover, the removal of TGF-β1 stimulus 
enabled the establishment of a metastable phenotype with concomitant E-cadherin presence at 
cell membrane and α-SMA expression in the cell cytoplasm. 
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In conclusion, we created a 3D in vitro TGF-β1-mediated EMT/MET system that makes use of 
RGD-modified alginate hydrogels that provide a well-defined and tuneable environment. The 
insights gained with this Master Thesis, may ultimate be useful for the establishment of a high-
throughput system for the study of cancer progression and metastasis. 
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RESUMO 
 
A transição epitelial-mesenquimal (EMT) trata-se de um processo biológico através do qual 
células epiteliais polarizadas sofrem modificações bioquímicas que lhes permitem adquirir um 
fenótipo mesenquimal. O processo de EMT encontra-se associado a uma concomitante 
diminuição de marcadores epiteliais (p. ex. Caderina-E) e aumento de marcadores 
mesenquimais (p. ex. Vimentina e α-SMA), bem como aumento da capacidade de migração e 
invasão, resistência à apoptose e maior produção de componentes da matriz extracelular (ECM). 
Células derivadas da transição epitelial-mesenquimal podem sofrer um processo de reversão, 
transição mesenquimal-epitelial (MET), através do qual recuperam um fenótipo epitelial. Por 
vezes, esta reversão não é completamente alcançada, originando um fenótipo metastável no 
qual se verifica uma expressão simultânea de características epiteliais e mesenquimais. A 
ocorrência da transição EMT tem vindo a ser demonstrada tanto em condições fisiológicas, 
nomeadamente durante a embriogénese e a cicatrização, como em situações patológicas, tal 
como a fibrose. Vários estudos sugerem que as transições EMT/MET podem também encontrar-
se envolvidas na progressão de cancro e desenvolvimento de metástases. De forma a averiguar 
tal hipótese, vários modelos de EMT têm vindo a ser implementados usando os clássicos 
sistemas dimensionais (2D). Todavia, estes modelos não contemplam a influência de uma 
estrutura tridimensional (3D) semelhante à matriz extracelular, o que permitiria uma melhor 
mimetização do microambiente in vivo, um importante moderador do programa EMT/MET. 
Desta forma, é necessário desenvolver sistemas in vitro melhorados, que simulem o 
microambiente tumoral de forma mais adequada, permitindo assim o estabelecimento de 
programas de EMT que fidedignamente representam a transição que ocorre in vivo. 
O principal objetivo desta Tese de Mestrado foi estabelecer um modelo 3D in vitro de indução 
de EMT/MET mediada por TGF-β1, em células EpH4 cultivadas em matrizes artificiais de 
alginato, com propriedades ajustáveis. Paralelamente, tínhamos como objetivo caracterizar o 
modelo 2D in vitro de indução de EMT/MET também mediada por TGF-β1, previamente 
estabelecido no grupo, através da caracterização das propriedades estaminais das células EpH4 
nos diferentes estadios do processo, bem como da sua capacidade de produção de 
metaloproteases da matriz (MMPs). 
Os nossos resultados demonstraram que as células derivadas do processo de EMT no sistema 
2D apresentam aumento das características associadas a células estaminais (resultantes de um 
enriquecimento da subpopulação CD29+/CD44+) e da produção de MMP9. Relativamente ao 
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modelo EMT/MET em 3D, as nossas descobertas mostram que o programa de EMT mediado por 
TGF-β1 é caracterizado por uma deficiente função de Caderina-E e aumento de marcadores 
mesenquimais tanto ao nível de expressão de ARN como de proteína (p. ex. Vimentina e α-SMA). 
Adicionalmente, com a remoção do estímulo de TGF-β1 foi alcançado um fenótipo metastável 
com presença simultânea de Cadherina-E, na membrana celular, e de α-SMA, no citoplasma. 
Concluindo, foi possível criar um sistema 3D in vitro de EMT/MET mediado por TGF-β1 baseado 
na utilização de hidrogéis de alginato modificado com RGD, que permitem um ambiente bem 
definido e regulável. As descobertas alcançadas com esta Tese de Mestrado poderão vir a ser 
úteis para o estabelecimento de sistemas de alto rendimento para a investigação em progressão 
de cancro e formação de metástases.  
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CHAPTER I 
Thesis Overview 
1. Thesis Context 
Epithelial to mesenchymal transition (EMT) has been described as a phenomenon through which 
epithelial cells undergo multiple biochemical modifications that enable them to 
transdifferentiate into cells that evidence a mesenchymal phenotype1. During this biological 
process, epithelial cells lose their characteristic intercellular adhesion and polarization, and gain 
mesenchymal features, namely enhanced production and deposition of extracellular matrix 
(ECM) components, along with enhanced migratory capacity and invasiveness2–4. EMT is a crucial 
embryonic developmental process that can be recapitulated in adulthood during wound healing 
and that may be harnessed by cancer cells5. Indeed, epithelial neoplastic cells may undergo EMT 
and develop the ability to invade through the basement membrane and metastasize, therefore 
allowing for cancer progression and systemic dissemination of the primary tumour, originating 
metastasis6. In fact, metastasis are responsible for more than 90% of cancer-related deaths and 
is currently handled as a dynamic and complex process that holds profound implications for 
cancer diagnosis, prognosis and treatment7,8. The success of the metastatic process is 
accomplished when the disseminated cancer cells give rise to a secondary tumour, which entails 
the reacquisition of an epithelial-like phenotype that can be the outcome of the reverse process 
of EMT, named mesenchymal to epithelial phenotype (MET)9. 
 
2. Problem Statement 
The metastatic process and particularly the contribution of the EMT/MET molecular programs 
to its success are difficult to study both in vitro and in vivo, due to the lack of proper models. As 
a matter of fact, the role of EMT in cancer remains dubious since it is difficult to prove and 
identify a full EMT phenotype in clinical carcinomas and metastases10. Some clinical observations 
may support the concept of a transient EMT that is only induced in a small number of cancer 
cells5. During the past 10 years a notable effort was made in order to develop biological models 
that could contribute to a better understanding of the EMT molecular regulation and signature. 
Nowadays, EMT studies are driven by the eagerness to discover new molecular targets and 
therapies, however there is a concerning gap between the results obtained using the in vitro 
systems and their clinical outcome. Therefore, improved biological systems that better mimic 
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the three-dimensional (3D) microenvironment of the tumour need to be developed in order to 
closely reproduce the EMT transcriptional program that occurs in vivo. The development of 
artificial 3D ECM-like matrices may constitute a valuable tool to unravel the molecular 
mechanisms underlying the metastatic process. 
 
3. Aims and Objectives of the Thesis 
The primary aim of this Master Thesis was to establish an advanced 3D culture model of 
EMT/MET induction that would be useful to complement previous studies performed using 
traditional two-dimensional (2D) and in vivo models. The model gathers near-normal mouse 
mammary epithelial cell line EpH4 and alginate hydrogels as synthetic ECM, to create a Tumour 
Growth Factor (TGF)-β1-induced EMT/MET model with tuneable biochemical and mechanical 
properties. This model is expected to facilitate the analysis of the cellular behaviour in a well-
defined and biologically relevant microenvironment; will allow the identification of several ECM 
features, to setup an EMT/MET induction within a 3D EpH4 culture; and will provide insight into 
cell-matrix interactions in this context. 
The first objective was to further develop the 2D in vitro model of TGF-β1-driven EMT/MET 
induction previously established in the group, by characterizing the stemness properties of the 
cells at different stages of the process, as well as their ability to produce Matrix 
metalloproteinases (MMPs). The second objective consisted on the establishment of the 3D 
model that comprised three main tasks, which are identification of the most suitable culture 
conditions (e.g. stiffness and cell density), determination of TGF-β1 concentration and the time 
of culture that is necessary in order to achieve each cellular stage of the EMT/MET process, and 
monitoring of cell behaviour in the 3D artificial environment, in order to evaluate the interaction 
between epithelial/mesenchymal cells with the surrounding environment, as an integrated 
system. The final objective was comparison between the 2D and the 3D in vitro models to 
understand the impact of the third dimension, in the study of EMT/MET processes in vitro. 
 
4. Thesis Outline 
Chapter I, Thesis Overview, entails a short context of the Thesis and the problem statement that 
together represent the motto of this project; the main aims and tasks of the project are also 
exploited in Chapter I. Chapter II, Introduction, gives a detailed background on the subject that 
underlies this Thesis, by gathering a review on the extensive knowledge on EMT, particularly 
related to cancer, and the state-of-the-art of in vivo and in vitro biological models that have been 
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developed, in order to study this process. Chapter III, Material and Methods, describes the 
methods that were implemented during this experimental work, as well as main materials that 
were used. Chapter IV, Results, reports the observations and findings that resulted from the 2D 
model study, and from the establishment and validation of the EMT/MET-induction model in 
the 3D system. Chapter V, Discussion, analyses the obtained results, compares the 2D and 3D 
EMT/MET systems and correlates them with other models described in literature, offering a 
critical perspective of the work developed. Chapter VI, Conclusions, reviews the main 
achievements of this work, their implications, limitations and potential applications. Future 
research opportunities and perspectives are addressed in the final chapter, Chapter VI. 
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CHAPTER II 
Introduction 
1. General introduction 
Epithelial cells are defined as cells highly polarized along a basal-apical axis, which normally 
interact with basement membranes via basal adhesive junctions. These cells are connected by 
basal and cell-cell adhesive contacts, such as tight and gap junctions, and they are arranged in 
mono or multilayers giving rise to the epithelium11. The epithelium is a robust tissue that 
supports the structure of embryos and organs, and acts as an effective barrier against 
pathogens. It is also recognized by its remarkable dynamic cohesion and adhesion capacity that 
mainly relies in the establishment of the abovementioned adhesive contacts1,11. Under normal 
settings, these cells present limited motility due to the fact that they can only migrate laterally 
along the basal surface12. In certain circumstances, such as embryogenesis, wound healing and 
cancer, epithelial cells may undergo the EMT transcriptional program that enable them to 
transdifferentiate into a mesenchymal phenotype1. Mesenchymal cells can be amoeboid or 
polarized in the anterior-posterior orientation and interact weakly with the ECM components 
and neighbouring cells leading to an enhanced migratory capacity and invasiveness, two key 
features of cells that undergo EMT3,4. The EMT process is not an irreversible conversion to a 
mesenchymal state; cells may suffer a reverse process – MET – by which they are able to partially 
recover an epithelial phenotype and associated features1,9,13. The microenvironment in which 
these events occur is a major regulator of the EMT/MET program, thus biomimetic model 
systems are necessary to study such influence. Over the past years several EMT studies have 
been performed contributing to the extensive knowledge about this program and related 
events. The in vitro studies are an essential complement to the in vivo experiments and they 
have been upgraded accordingly to current technology, evolving from monocultures in 
monolayer to co-cultures systems, complex 3D environments, microfluidics systems and high-
throughput (HT) models. The creation of systems with increasing complexity intends to achieve 
a more reliable representation of the in vivo microenvironment thereby enabling a consistent 
and improved study the EMT/MET biological dynamics. 
 
Establishment of a 3D model of EMT/MET-induction using molecularly-designed ECM-like hydrogels 
6 | Chapter II – Introduction 
 
2. Epithelial to Mesenchymal Transition 
 The biological context of EMT 
EMT may occur under diversified, although highly specific settings leading to different functional 
and physiological responses. Accordingly, three main categories of EMT – type 1, 2 and 3 – have 
been proposed depending on the biological context in which the phenotypic transition is 
settled1. These three EMT types represent distinctive processes that rely on different 
biochemical and genetic modification programs that are not yet completely understood. 
EMT type 1 comprises a well-known multi-step process that plays a central role during 
embryonic morphogenesis and development. Particularly, EMT type 1 is crucial for embryo 
implantation and organ development, since epithelial cells are not endowed with the flexibility 
required for the development of complex body structures as mesenchymal cells are1,11,14,15. 
Indeed, the differentiation of specialized cells and the complex 3D structure assembly that 
occurs, for instance, during the internal organs formation, requires sequential rounds of EMT 
and MET programs, giving rise to the nominations of primary (e.g. gastrulation), secondary (e.g. 
nephogenesis) and tertiary (e.g. heart formation) EMT13,14. 
EMT type 2 occurs as part of the inflammatory response during wound healing, tissue 
regeneration and organ fibrosis, in order to generate fibroblasts and related cells that enable 
the reconstruction and remodelling of the damaged tissue1. For instance, during skin wound 
healing, keratinocytes recapitulate the EMT process through the acquisition of an intermediate 
phenotype, called “metastable” phenotype, through which cells display simultaneous epithelial 
and mesenchymal features that allow the movement of these cells without the complete loss of 
contact16. The wound healing of the ovarian surface epithelium at each menstrual cycle in 
another example of the importance of EMT type 217. In contrast to EMT type 1, EMT type 2 can 
be associated to disease, since it enables the conversion of epithelial cells into myofibroblasts 
that secrete excessive amounts of collagen, which accumulate in the organ creating fibrotic 
collagen networks that compromise organ function13. This EMT-mediated conversion during 
fibrosis was already shown in several organs, such as kidneys, liver, lung and heart18–21. 
The third type of EMT is also associated to pathophysiological conditions as it has been proposed 
to occur in neoplastic cells and is thought to be a crucial step for cancer progression. Due to 
genetic and epigenetic alterations that occur in tumour cells, mechanisms thought to regulate 
EMT suffer modifications that lead to outcomes far different that those described for EMT type 
1 and 21. In the initial steps of carcinogenesis in epithelial tumors, transformed epithelial cells 
are associated to a gaudy proliferation and angiogenesis, and in the final stages these cells 
develop the ability to invade through the basement membrane and some of them to metastasize 
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leading to a systemic dissemination of the tumour. This malignant phenotypic change has been 
proposed as being consequence of the activation of an EMT program; furthermore, the eventual 
dissemination of these cells to originate secondary tumours at distant sites implies the 
reacquisition of an epithelial phenotype, which may occur via MET6. In some cases, epithelial 
cells may not be fully transformed into mesenchymal cells, thus accumulating features of both 
epithelial and mesenchymal phenotypes, suggesting the occurrence of a metastable 
phenotype22 that could be the result of a partial EMT1,23. 
The physiological and pathophysiological conditions in which EMT may be activated, illustrate 
the biological relevance and highlight the need to study the fundamental mechanisms 
underlying this process.  All three EMT types have been subject of extensive research, however 
there are many open questions that could break new grounds for improved therapies against 
cancer, chronic fibrosis and other EMT-associated diseases24. The specific signal or signals that 
trigger EMT and MET, the molecular stakeholders that orchestrate the response to those signals 
and the signalling pathways involved are some of the questions that are still not fully 
understood, particularly in EMT type 2 and 3. 
 
 Cellular and molecular basis of EMT 
The molecular modifications inherent to the EMT program have been associated to key 
signalling pathways that may be responsible for the implementation of the cellular response to 
extracellular signals arising from the cell microenvironment (Figure 1), as it is the case of TGF-β 
ligand. Indeed, TGF-β signalling pathway is one of the best studied mechanism of EMT induction 
and its relevance for tumour progression has been intensively investigated and reviewed25–29. 
Under normal circumstances, TGF-β is a pleiotropic cytokine that is essential to development, 
differentiation and homeostasis of almost all kinds of mammalian cells and tissues, being a 
suppressor of uncontrolled proliferation and transformation25,29. However, dysregulation of 
TGF-β signalling may confer an oncogenic behaviour to this molecule that induces EMT and 
metastasis. Such functional switch is known as “TGF-β Paradox” and it has been studied in order 
to further understand the mechanisms underlying EMT induction and eventually to identify 
novel pharmacological agents that could prevent such mechanisms26. TGF-β superfamily is 
considered as primary inducer of EMT and it was found to be capable of inducing all three types 
of EMT9. Although different elements of the family are responsive to different extracellular 
signals, they share the same transcriptional network and cellular response. To initiate the TGF-
β signalling pathway, TGF-β ligands bind with high affinity to TGF-β receptor type II (TGFβRII), a 
constitutively active cell surface receptor belonging to the serine/threonine kinase family. When 
the ligand binds to TGFβRII, a conformational change occurs in the receptor allowing the 
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recruitment of an appropriated TGF-β receptor type I (TGFβRI) and therefore, the formation of 
a tetrameric complex. TGFβRI can directly phosphorylate the receptor Smad (R-Smad) enabling 
the formation of a complex of two R-Smads and one Smad4 that accumulates in the nucleus and 
prompts the EMT transcriptional program30. The activation of Smad3 by TGF-β may induce the 
activation of the Notch pathway that regulates the expression of BMP family members, Notch 
ligands (e.g. Jagged 1) and targets (e.g. Hey1) and that is associated to E-cadherin repression, 
enhancement of MMP2/9 and alfa-smooth muscle actin (α-SMA) expression, some of the well-
known EMT markers31–33. TGF-β signalling may also induce non-Smad pathways, including 
Mitogen-activated protein kinases (MAPKs), Phosphoinositide 3-kinase/Akt (PI(3)K/Akt) and 
Nuclear-factor kappa B (NFκB)13,34,35. All of these pathways converge in the initiation of a 
transcriptional program that leads to the inhibition of epithelial features and induction of a 
mesenchymal phenotype. Such outcome results from the activation of key transcription factors 
such as Snail, Slug, Twist, ZEB1/2, HMGA2, coupled with changes in microRNA (miR) expression, 
as it is the case of the downregulation of miR-200 family27,36. This specific transcriptional 
program accounts for characteristic changes in cell-surface, cytoskeletal and ECM protein 
expression that are understood as EMT markers. The decreased expression of E-cadherin, 
Cytokeratin and Laminin1, and enhanced expression of N-cadherin, Vimentin and Fibronectin 
are some of the most common reported changes during EMT at the protein level. TGFβRII may 
also be triggered in tight junctions where Occludin, Claudin and JAM proteins bind to ZO family 
proteins, connecting the cell to its neighbour and regulating its own polarity. Once activated, 
TGFβRII facilitates the interaction between Par6 and Occludin, via Par6 phosphorylation, leading 
to RhoA inhibition by Smurf1 and consequent polarity loss9,37.  
Besides the TGF-β-mediated EMT induction, other signalling pathways have demonstrated an 
important role in the induction of this event. Wnt signalling can be correlated to the inactivation 
of glycogen synthase kinase (GSK)-3β, that blocks the activation of the transcription factors Snail 
and LEF-1, thus inducing the EMT and cell migration via E-cadherin expression decrease and 
enhanced mesenchymal markers9,38–40. The Tyrosine kinase receptors (TKR) signalling may 
promote EMT through the induction of Ras-MAPK pathway that eventually activates the 
transcription factors Snail and Slug13. Met, FGF, IGF, EGF, HGF and PDGF families are some of the 
TKRs inherently associated with the 3 types of EMT9,17,41. The NFκB pathway can also be seen as 
an important regulator of type 2 and type 3 EMT, since it leads to the induction of Snail 
transcription in carcinoma cell lines and mesothelial fibrosis. Indeed, this pathway proved to be 
fundamental for EMT implementation, since the EMT is blocked when NFκB pathway was 
inhibited by IκB13,34. 
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Figure 1. Summary of major regulators and signalling pathways involved in EMT progression. 
Retrieved from Lamouille, Xu and Derynck (2014)42. 
 
Despite of the several EMT induction mechanisms, the outcomes of the transcription program 
that is implemented always seem to include the loss of functional E-cadherin, which is why this 
feature is recognized as one of the most important hallmarks of EMT. Indeed, the loss of E-
cadherin is widely correlated to all three types of EMT and it has been associated with carcinoma 
progression and poor prognosis both in human and mouse tumours43. E-cadherin function may 
be impaired through different mechanisms, which may be developed at the genetic, epigenetic, 
transcriptional and post-transcriptional levels44. Although rare, mutations in the E-cadherin gene 
(CDH1) may lead either to the protein absence or truncation, thus impairing E-cadherin 
mediated cell-cell adhesion. CDH1 inactivating mutations were firstly found in diffuse-type 
gastric carcinomas45; now, they are known to occur in other types of cancers, such as lobular 
breast carcinomas46 and synovial sarcomas47. Regarding the epigenetic mechanisms, 
hypermethylation of the 5’ CpG islands of CDH1 promoter seems to be an important mechanism 
of E-cadherin silencing and it has been reported in some types of cancers as it is the case of 
invasive breast ductal carcinoma48, esophageal squamous cells carcinoma49 and gastric cancer50. 
Indeed, in gastric cancers the hypermethylation of CDH1 was found to be correlated with cancer 
aggressiveness and metastasis51. The transcriptional repression of CDH1 can be accomplished 
through the EMT direct activation of zinc-finger transcription factors Snail, Slug and ZEB1/2 that 
are able to directly bind to E-box repressive elements in the promoter of CDH152,53. Nevertheless, 
some EMT inducers, such as Twist1, FOXC2 and Goosecoid, have shown the ability to activate 
the EMT program in epithelial cells without binding directly to CDH1 promoter9. The post-
transcriptional modification of E-cadherin commonly occurs through phosphorylation or 
glycosylation. For instance, adherens junction formation can be negatively regulated by tyrosine 
kinases, such as Met and Src, which phosphorylate β-catenin and the short cytoplasmic tail of E-
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cadherin54. On the other hand, the loss of E-cadherin function during EMT may be accomplished 
by a specific modification of the E-cadherin glycosylation via Mgat3 glycogene expression and 
GnT-III-mediated glycosylation55. Despite the countless reports that show the loss of E-cadherin 
function in cells undergoing EMT, it is very important to highlight that when such loss occurs in 
normal epithelial cells, the result is often cell death rather than EMT, which suggests that E-
cadherin loss is not, per se, an EMT inducer9. The loss of cadherin is associated to a cadherin 
switch in which N-cadherin is up-regulated56 and has an important role in tumour progression. 
Furthermore, P-cadherin has also been associated with tumour progression and increased 
migration and invasion57, however its contribution cannot be generalized due to divergent data 
obtained from independent studies in different types of cancer45. 
The mesenchymal differentiation, cell migration and invasion are also recognized hallmarks of 
EMT and they can be accomplished mainly through post-translational modifications that 
regulate the activity, subcellular localization and stability of SNAIL, basic helix-loop-helix (bHLH) 
and ZEB factors (Figure 2), as described by Lamouille, Xu and Derynck42. 
 
 
Figure 2. Post-translational modifications in major EMT regulators SNAIL, bHLH and ZEB. Adapted from 
Lamouille, Xu and Derynck (2014)42.  
 
The depicted signalling pathways are very complex and can regulate numerous elements such 
as transcription factors, effector proteins and microRNAs; additionally, other pathways can be 
involved in EMT induction. Hence, the precise role of each component and how it affects the 
EMT program requires further clarification. 
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 Role of EMT in cancer 
The concept of hallmarks of cancer proposed by Hanahan and Weinberg in 2000, and reviewed 
in 201158, gathered important insights that are seen as crucial pieces in the complex biological 
puzzle that is cancer. The great knowledge produced worldwide around the EMT mechanisms 
and its key drivers shows that there is a correlation between EMT implementation and several 
cancer hallmarks, such as activation of invasion and metastasis, immune system evasion and cell 
death resistance, which supports the existence of EMT type 3.  
Several independent studies have shown that EMT type 3 may be induced mainly by TGF-β and 
Wnt signalling pathways via microenvironmental stimuli59,60. Hypoxia has also been revealed as 
a driving force of EMT events. At early stages, hypoxia supports the Snail up-regulation via 
Reactive oxygen species (ROS)-dependent GSK-3β inactivation and Notch signalling61 and Twist 
expression may be induced via Hypoxia-inducible factor-1alpha (HIF-1α) activation62. In late 
stages of the EMT process, invasion, basement membrane degradation and ECM remodelling 
might be promoted by HIF-1α-mediated Wnt/β-catenin pathway63. Extracellular matrix 
molecules, such as Collagen type I, may as well contribute to EMT activation64. Collagen type I 
interacts with α2β1 integrin triggering the increase of Akt, GSK-3β and IκB phosphorylation via 
integrin linked kinase (ILK) that eventually enables the activation of EMT-related transcription 
factors, such as NF-κB, Snail and LEF-1, as well as E-cadherin down-regulation38,65. Beyond the 
multitude of extracellular signals that could be further described in EMT type 3, it is equally 
important to note the existence of some intracellular stimuli that have been identified as EMT 
promotes. One of those cases is the intracellular calcium signalling that has been studied in the 
growth of the primary tumour context and that recently showed some evidences that it may 
have an important role in cancer cell invasion and migration66,67. 
EMT type 3 relies on a transcriptional program that is different from the other two types of EMT, 
therefore the outcomes of this program will also differ from the ones observed in EMT type 1 
and 2. In addition to the general hallmarks of EMT, other cell features were already shown such 
as cell death evasion, cell cycle and senescence regulation, angiogenesis, immunosuppression 
induction, resistance to therapy, and also acquisition of stem cell properties, in close 
resemblance to cancer progression6,9,68. Indeed, the tumour metastasis process is only possible 
due to a core of tumour cells that retain the self-renewing ability and stem cell features that 
enable them to initiate new tumours. These cells, named cancer stem cells (CSCs), can be 
recognized by a CD44high/CD24low phenotype, which allowed the identification of their presence 
in breast, colon and brain carcinomas69–71 or through a CD44high/CD29high phenotype in squamous 
cell carcinomas72. Through the induction of EMT in immortalized human mammary epithelial 
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cells, Mani and colleagues showed that cells undergoing EMT also present features of CSC, 
suggesting that EMT can be involved in the formation of CSC73. The hypothesis of EMT/MET 
occurrence in these cells could explain how cells that gain motility and invasion capacity are also 
able to disseminate and initiate another tumour in distant tissues and organs73,74. Tsuji and 
colleagues suggested that EMT cells might cooperate with non-EMT cells in order to allow a 
spontaneous metastasis process. In their study, EMT cells induced extracellular matrix 
degradation enabling invasion and intravasation of both EMT and non-EMT cells75. 
Unfortunately, none of the studies performed until now demonstrates how these cells can 
initiate a tumour with similar features in a different microenvironmental niche76. Recent studies 
showed that the acquisition of an EMT-associated stem cell phenotype can be correlated with 
decreased expression levels of miR-200c – by p53 loss of function – and miR-203, suggesting 
that the restoration of the expression levels of this microRNA family may inhibit metastasis77–79. 
Despite of the lack of irrevocable evidences of EMT in human cancer tissues, the increasing 
number of studies reporting the potential role of EMT in promoting CSC features and 
chemoresistance8,80, lead some authors to suggest the development of therapies based on the 
use of CSC or EMT markers to target CSCs and consequently reduce the tumour growth, 
metastasis and patient chemoresistance81. Others, propose the use of drugs to induce cancer 
cells to differentiate into benign stromal fibroblasts82. 
The strong evidences of the EMT importance for tumour development and dissemination, and 
the hypothetical role of MET in the establishment of metastases (Figure 3)83 suggest that 
EMT/MET and associated signalling pathways could be useful to improve cancer treatment and 
find new cancer therapies. Moreover, the identification of clinically validated EMT/MET markers 
would lead to an improved and perhaps earlier diagnosis, which could be translated into better 
prognosis. Such expectation has been nourishing several studies that aim to magnify the 
knowledge about EMT and its potential role in cancer therapy. 
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Figure 3. Two proposed mechanisms of tumour cell dissemination in which EMT and MET are involved. 
A. EMT as a complete or partial process. Primary epithelial tumour cells (blue cells) undergo EMT either 
partially (turquoise) or completely (green), and then undergo MET at a distant site to form the metastatic 
lesion. B. EMT and cell cooperation. Mesenchymal cells (green) invade the vasculature, enabling epithelial 
(blue) cells to pass through as passengers. Adapted from Krebs et al. (2014)84. 
 
3. In vivo and In vitro Models to Study EMT 
 In vivo models 
There is no doubt about the outstanding contribution of the scientific studies performed in vivo 
for cancer research purposes and for biomedical research in general. In vivo studies are currently 
the ultimate barrier to the implementation of new therapies and treatments in all therapeutic 
classes, and for that reason these models are extensively used for screening purposes. These 
models are also largely employed to study the complex biological environment and dynamics, 
however it is important to highlight the high cost and ethical issues intrinsically associated with 
their implementation. Furthermore, these models are very time consuming and in some cases 
they fail to reflect the human condition, which may lead to a failure in the translation of the 
research outcomes85–87. In the particular case of cancer research, the most common models 
arise from the surgical implantation of tumour cells in animals, which are frequently 
immunodeficient, or the generation of genetically-engineered models that accomplish a 
spontaneous tumour formation88. A major lack in this field is the development of animal models 
that recreate deadly cancers89. Additionally, classical animal models and in vivo studies are 
associated to a higher degree of unpredictability of the model behaviour and ethical issues. 
These limitations suggest the need for better animal models that would enable to follow the 
spatial and temporal modifications in tumour cells. Until now, in vitro 2D systems have been 
used as an additional and complementary tool in order to overcome the considerable 
restrictions of in vivo models. Regarding the particular case of the EMT study, the in vivo study 
is even more complex due to the lack of proper biomarkers that would allow the identification 
of the EMT associated cells90. Indeed, despite the large number of biomarkers identified through 
2D standard in vitro cultures, the success rate of their implementation in clinics is extremely low 
which translates the need for more reliable and representative models91. 
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 EMT in vitro models 
3.2.1 2D EMT studies 
The conventional 2D studies accomplished in flat culture plastic have given rise to major 
advances in the understanding of EMT. These systems are particularly interesting to study the 
effect of individual variables and factors, or to achieve constant and stringent conditions of 
analysis92. In fact, these models provide almost total control over the biochemical and 
topographical properties of cells and they can be easily manipulated and integrated with a wide 
range of techniques93. For all these reasons, 2D models have an important role in understanding 
the influence of the individual EMT intervening factors in the global biological process and to 
relate them with the observed outcomes. 
Although 2D studies represent an easy, flexible and accurate way to analyse EMT related effects, 
they fail in reconstructing the 3D complex environment in which the EMT takes place. One of 
the major criticisms concerning studies in 2D is that when cells are removed from their biological 
environment they tend to show a non-natural behaviour that may induce modifications in the 
global process. Once cultured in monolayer, cells become polarized with only part of their 
surface anchored in the substrate while the remaining surface is exposed to the culture media, 
hence cells are limited to their planar and spread morphology which can lead to the loss of their 
tissue-specific functions93,94. When tissue derived cells or cell lines are cultured in 3D scaffolds 
they tend to develop complex networks of cell-cell and cell-matrix interactions that affect the 
penetration of nutrients, biological factors (hormones and growth factors) and drugs, thus 
influencing cell growth, differentiation and death95. Other restrictions of 2D models are the lack 
of stromal components and reduced cell-matrix interaction, which are essential stimuli found in 
the in vivo environment95. In order to overcome some of these limitations, several studies 
attempt to incorporate ECM-like components on the 2D model by coating the flat dishes with 
various proteins, such as Collagen, Fibronectin and Laminin, creating a natural basal adhesion. 
The most complex 2D models also include co-cultures that intend to recreate the natural 
intercellular communications. In any case, cells remain in a monolayered arrangement that 
impairs the generation of a multidimensional structure. 
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3.2.2 Advances of 3D in vitro models 
The limitations of both 2D cell models and in vivo animal models provided the opportunity to 
the establishment of 3D models that aim to bridge the outcomes derived from the traditional 
models, and simultaneously to connect cell culture and human biology, both in physiological and 
pathological conditions. Such models attempt to recapitulate the tumour biology at all levels, 
which includes tumour gene signatures, cellular morphology, proliferation and differentiation, 
phenotypic heterogeneity of the population and the tumour microenvironment, through a fine 
balance between 2D in vitro simplicity and in vivo complexity (Figure 4). 
 
Figure 4. Balance of main considerations of in vivo and in vitro models. 3D cultures that recreate the 
complex cellular microenvironment more precisely than traditional 2D cultures, due to the incorporation 
of multiple physical, mechanical and chemical cues that arise from ECM–cell and cell–cell interactions. 
Animals do not capture important facets of human behavior and they are not feasible for HT screening 
applications. Adapted from Alemany and Semino (2014). 
 
The differences between 2D and 3D systems were noticed for the first time in the beginning of 
the 20th century, when Ross Harrison cultured embryonic frog cells in different conditions and 
observed a different cell behaviour in 2D and 3D hanging drop cultures96. Another type of 3D 
cell culture had its beginning in 1957 when McLimans and its colleagues reported a “disturbing 
feature” of HeLa cells grown in shake culture that was the formation of “large matrices of 
cells”97. This was the first time that a multicellular spheroid derived from mammalian cells was 
described. Three years later, in 1960, Wichterle and Lim proposed the use of poly(2-
hydroxyethyl methacrylate), also known as pHEMA, in contact lenses giving rise to the concept 
of hydrogels98. It took twenty years to expand this concept to cell culture that came in the first 
place through cell encapsulation99. The 3D culture concept was brought to the cancer field by 
Miller and its colleagues that showed that tumour cells exhibit greater drug resistance when 
grown as multicellular spheroids in a collagen gel than when cultured in monolayer100. Since 
then, many important achievement have been accomplished as it is the case of the pioneer work 
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of Mina Bissell that used 3D culture systems to model the molecular mechanisms underlying 
breast cancer cell invasion and revealed that when cells from tumour of epithelial origin are 
cultured in Matrigel, their shape is changed and resembles what is seen in in vivo tumour 
progression101. These findings sparked the interest of the scientific community, which led to the 
improvement of the 3D cell culture systems. Important advances were achieved in the field of 
biomaterials, giving rise to the concept of biologically active materials. The bioactivity of 
synthetic polymers could be accomplished by the incorporation of cell-recognition sites, such as 
adhesion factors and enzymatic cleavage moieties102. One example of those bioactive 
biomaterials are the polyethylene glycol (PEG) hydrogels designed by West and Hubbell (1999) 
that incorporated peptide domains susceptible to cellular proteases, which allowed the hydrogel 
degradation by cells103. A few years later, the work of Mooney’s group in adapting scaffolds 
initially developed for tissue engineering purposes for cancer research, allowed for the first time 
the combination of these scaffolds with human carcinoma cells for in vitro and in vivo 
experiments104. Since then, many other groups have expanded the applications of the 3D in vitro 
models in cancer, for instance, Hutmacher and Clements lab developed 3D in vitro models for 
breast and prostate cancer bone metastasis90 and currently there are several groups trying to 
develop HT systems to produce and analyse 3D cultures, which can be very important to improve 
the screening of anticancer drugs and to develop personalized therapies.  
According to the tumour microenvironment and its characteristics, or a particular 
process/feature that is aimed to mimic, different 3D models can be used, differing not only in 
their composition but also in terms of cell culture methodology and analysis (Table 1). Regarding 
the composition of these systems, they can be constituted by purely natural to purely synthetic 
materials105. Models derived from natural materials encompass as main advantages their 
cytocompatibility, ease usage, the ability to create a porous matrix or fibrous structure, and the 
possibility of modulating the stiffness simply through modulation of polymer composition and 
gelling conditions. Additionally, ECM-derived materials are provided with bioactivity due to the 
presence of cell adhesion sites in their composition. Despite of the broadly usage of these 
materials, they present relevant limitations, such as batch-to-batch variability and their complex 
or sometimes unknown molecular composition that challenges the reproducibility of the 
experiments. While studying EMT, it is important to understand that the unknown and variable 
composition on growth factors, namely TGF-β, may strongly compromise the replicability of the 
outcomes. Some examples of naturally derived materials are Matrigel® (derived from the 
basement membrane of murine sarcoma), ECM components from animal tissues such as 
Collagen type I, Laminin and Fibrin, and components derived from other biological sources as it 
is the case of Alginate106 and Chitosan107. Both Matrigel and Collagen have been largely used in 
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cancer research, and EMT studies are not an exception, however they present weak mechanical 
strength and the modification of the matrix mechanics often alters the matrix biochemistry. 
Alginate is a natural polymer derived from polysaccharides that has been used in tissue 
engineering, for instance to transplant cells108. Nevertheless, 3D alginate scaffolds, such as 
AlgiMatrixTM, have already proved their value as tumour models, namely for anticancer drug 
screening109. The typical slow biodegradation of the alginate hydrogels93,110 can be adjusted 
through their partial oxidation, combination of polymer chains with different molecular 
weight111 or even the incorporation of MMP-sensitive peptides112.  
Synthetic materials can also be used to engineer 3D models for cancer research, being their main 
advantage the great control over the experimental conditions. Additionally, they provide batch-
to-batch uniformity and allow a selective tuning of physical and biochemical composition. The 
major lack of these models is the absence of intrinsic bioactivity since their ultimate goal is the 
recreation of a physiological microenvironment that mimics as closely as possible the in vivo 
scenario. Therefore, hydrogels and scaffolds based in synthetic materials can be modified giving 
rise to hybrid artificial matrices. The incorporation of cell adhesive peptides (e.g. Arginine-
Glycine-Aspartic acid (RGD) and Tyrosine-Isoleucine-Glycine-Serine-Arginine (YIGSR)) and 
proteins (growth factors); the sensibility to cellular matrix-proteases (e.g. MMPs); and the 
modulation of the scaffold stiffness and surface topography are some of examples of matrices 
modifications93,113,114. Among the most commonly used synthetic materials are PEG115, 
poly(lactide-co-glycolide) (PLG)116 or polyacrylamide (PA)117. PEG hydrogels are biocompatible 
and resistant to protein adsorption, since they have high hydrophilicity, neutrality and mobility. 
PEG bioactivity can be easily tuneable and controlled, and it has been used as an hydrogel to 
culture different types of cells118,119. PLG is a synthetic and biocompatible polymer that allows 
for an easy reproduction and is convenient to use, which enables its utilization in a large-scale, 
for instance for cancer progression research and antitumor drug screening104. PA models are 
ideal to study mechanoregulatory mechanisms in the tumour; indeed, these models enabled 
researchers to understand that matrix stiffness improves tumorigenesis and that increased 
cellular traction stresses, as a response to increased stiffness, may be considered as an index of 
enhanced malignant potential120.  Other synthetic materials can be used depending the 
microenvironment that is aimed to mimic, thus enabling the study of different metastatic sites. 
For instance, poly(lactic acid) (PLA), poly(glycolic acid) (PGA) or the combination of these two 
polymers provide a very high stiffness that can be used to biomimic the bone ECM121. 
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Table 1. Most common 3D cell culture methodologies. 
Cell culture Methods Fundamentals 
Multicellular 
Spheroids 
Cells undergo self-assembly when in the absence of an attachment surface 
or scaffold, leading to the formation of cellular aggregates122 
 Spinner culture 
Constant stirring cell collision, thus avoiding single cells in suspension to 
settle and promoting the spheroid formation.122,123 This technique allows the 
formation of heterotypic spheroids and the control over spheroid 
characteristics via medium changes, stirring time and agitation speed. Mass 
diffusion along the spheroid can be promoted by fluid movement, avoiding 
the gradient of soluble components. This process can be easily scaled up, 
however it cannot be used for culturing low cohesive, shear sensitive or 
adherent cells. Additionally, cell visualization during aggregation is not 
possible due to the constant mixing.122,124 
 Liquid overlay 
Cells are seeded in flat tissue culture dishes made of low-adhesive surface 
(e.g. coated with agar, agarose and pHEMA) and spheroid formation is 
achieved by rocking the plates, together with a small amount of shaking. This 
technique is easy to perform, yet spheroids present a heterogeneous size 
and shape.122,124 
 Rotating wall vessel 
Cell suspension is slowly rotated about an x-axis, creating a microgravity 
environment.95 As cells start to aggregate, the rotation speed is increased to 
avoid its settlement. Through this method high yield of spheroid formation 
can be achieved, using low levels of shearing forces. Moreover, the culture 
medium can be easily changed by perfusion allowing long-term studies or 
changing conditions during the process.125 Nevertheless, the size of the 
spheroids is highly variable and it is difficult to track spheroid assembly. 
 Hanging drop 
A small volume of a cell suspension is pipetted in the inside part of the lid of 
a tissue culture plate, and when the lid is inverted, the drop will stay attached 
due to surface tension and spheroid formation occurs through gravity-
enforced cell self-assembly.126,127 This method allows for a high-throughput 
spheroid formation, with a fine spheroid size and cellular composition 
regulation.128 In this system, it is difficult to track spheroid assembly and to 
change or add cell culture medium/drugs. 
 Concave plate 
Cells are isolated in microwells of non-adhesive substrates allowing them to 
cluster and grow into compact cell spheroids through cell-cell adhesion. This 
method enables the creation of a high-throughput system of spheroid 
production, as well as easy track of spheroid formation and medium change. 
 External force 
External forces, such as ultrasound, electric and magnetic fields induce an 
increase in cell concentration into a high density that facilitates spheroid 
formation.  Physiological cell changes induced through this method are still 
not well characterized.122 
  
(Table 1 continues in next page) 
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Scaffolds 
Cell-cell and cell-matrix interactions induce cell spheroid mimicking the  ECM 
behaviour95,105 
 
Microporous 
scaffolds 
Cells interact with the substrate being lodge within the porous. Due to the 
large size of those porous (≈100 µm), cells tend to adhere and form few cell-
cell interaction which leads to a 2D-like culture rather than a 3D culture.105 
 
Nanofibrous 
scaffolds 
Cells interact with a fibrous substrate that provides a 3D architecture for cell 
culture. Yet, these substrates tend to be structurally weak to handle the 
stress needed for mechanotransduction.105 
 Hydrogels 
Cells interact with crosslinked networks that are characterized by high 
porosity and water content that enable free diffusion of nutrients, oxygen, 
growth factors, cell metabolites and other soluble components.93,105 These 
matrices closely mimic the nature of most soft tissues and allow the study of 
cell behaviour in different conditions, since the medium can be easily 
changed. Retrieving the cells from the 3D culture seems to be the main 
difficulty associated to this method.124 
 
Regardless the cell culture methodology or composition of the 3D model, epithelial cells tend to 
form cellular spheroids that provide a more physiological arrangement that the 2D cultures 
(Figure 5), that can be generally described by additional mechanical inputs, dissimilarity in 
morphology, distinct cell adhesion and contraction, as well as modified intracellular signalling, 
which may ultimately change the functional behaviour of these cells129,130. 
 
 
Figure 5. Adhesive, topographical, mechanical, and soluble cues in 2D and 3D. The cues encountered by 
a cell are strikingly different between an ECM-coated glass or plastic surface (2D) and a typical 3D ECM. 
Adapted from Baker and Chen (2012)130. 
 
 
 
2D culture 3D culture 
(Table 1 continuation) 
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3.2.3 EMT studies using 3D in vitro models 
In an attempt to create research approaches that better resemble the in vivo conditions in which 
EMT takes place, many groups have been exploiting different 3D models based on a wide range 
of materials and technologies. This divergence of models also differs in respect of the EMT 
inducer; indeed, TGF-β remains one of the most common EMT inducers131–135, however other 
stimuli have also been studied such as Snail136, BMP7137, HGF138, collagen type I38,65,139,140, matrix 
stiffness141–143 and endothelial cells co-culture144.  
The initial 3D studies on EMT were designed to address the cellular behaviour and cell-matrix 
interactions. The work of Maschler and colleagues is a great example of such studies. Using EpH4 
cells transformed by oncogenic Ha-Ras, this group showed that TGF-β1 induced EMT results in 
secretion and deposition of the extracellular matrix protein tenascin-C when cells are cultured 
in 3D collagen scaffolds but not when traditionally cultured in 2D145. Indeed, tenascin-C was 
found to be overexpressed in breast carcinomas and it is associated with a migratory and 
invasive tumour cell phenotype146. Additional studies on this model also showed the important 
role of functional α5β1 integrin in cell invasiveness associated with EMT147 and that Annexin A1, 
an important cellular mediator that is highly reduced during tumour progression and metastasis 
in breast cancer and that correlates with reduced patient’s survival, is an efficient 
EMT/metastasis suppressor148,149. In an independent study, Loessner and colleagues compared 
the cell-ECM interactions between two human cancer cell lines – epithelial ovarian cancer and 
serous adenocarcinoma cell lines – that despite the similarity in 2D culture, showed different 
proliferation rates in RGD-modified PEG hydrogels113. The authors showed that proliferation in 
the hydrogel was dependent on cell-integrin engagement but also on the cellular ability to 
remodel the surrounding matrix. In fact, the surrounding matrix plays a crucial role in defining 
the EMT success, both in a biochemical and in a mechanical manner. For that reason, some 
studies propose models with independently tuneable chemical and mechanical properties to 
better understand the EMT process. In 2012, Gill and colleagues proposed a PEG modified 
scaffold for miR-200-dependent EMT/metastasis on 344SQ metastatic cell line and showed that 
matrix stiffness and concentration of cell-adhesive ligands influences the epithelial 
morphogenesis at different levels, namely at the expression of epithelial markers, apoptosis, 
proliferation and lumenization of epithelial spheres in MMPs-degradable hydrogels118. They also 
showed a successful EMT induction by TGF-β1 regardless the matrix composition. Markowski 
and colleagues exploited this question by culturing alveolar epithelial cells (RLE-6TN cell line) on 
top of PA gels with different concentrations of bisacrylamide and different recombinant variants 
of the RGD sequence in Fibronectin150. Their work suggested that TGF-β1 induced EMT is only 
Establishment of a 3D model of EMT/MET-induction using molecularly-designed ECM-like hydrogels 
 
Chapter II – Introduction |21 
 
supported on stiff substrates that present adhesive ligands that preferentially bind αv integrins. 
Recently, it was shown that the increase of ECM stiffness alone may induce malignant 
phenotypes, however that effect can be abrogated with the concomitant increase of basement 
membrane ligands151. This phenomena was observed in the human mammary epithelial cells 
(MCF10A) cultured in a matrix composed by a combination of Matrigel and alginate and it is 
dependent on integrin β4, Rac1 and PI3K signalling pathway, as suggested by the authors. 
Nevertheless, stiffness is not the only physical property that should be considered and the 
topography of the culture surface has becoming more and more relevant. Last year, Foroni and 
colleagues demonstrated that aligned-PLA scaffolds are prone to produce more aggressive 
phenotypes than PLA fibers randomly orientated152.  
With all the knowledge conquered with these studies even more complex systems have been 
created. Decellularized tissue matrices, co-cultures in 3D structures, microfluidic devices and 
high throughput methods have been produced and tested in order to develop new methods for 
drug screening, diagnosis or personalized treatments related to cancer and EMT in particular 
(Table 2). All of these engineered–based systems have been developed to increase complexity 
of standard methods and simultaneously reduce the complexity of the disease. Nevertheless, 
these systems need to be further improved to truly fill the gap between in vitro and in vivo 
outcomes. 
Establishment of a 3D model of EMT/MET-induction using molecularly-designed ECM-like hydrogels 
22 | Chapter II – Introduction 
 
Table 2. Innovative 3D in vitro models for EMT and cancer research 
 
Relevance System Cell Model Reference 
Usefulness of the radial flow type bioreactor for 3D 
culture systems 
Hydroxyl apatite matrix in a radial flow type bioreactor A431 squamous carcinoma cell line Shibata et al. (2009) 153 
Hydrogel-based microfluidic system for tumour 
spheroid formation and drug screening 
In situ gelation of alginate within microchannels LCC6/Her-2 breast tumour cells Chen et al. (2010) 154 
High-throughput system for tumour spheroid 
formation and drug screening 
384-well platform for hanging drop spheroid culture 
COS7 kidney fibroblast cells; 
ES-D3 embryonic stem cells; A431.H9 
epithelial carcinoma cells 
Tung et al. (2011) 128 
High-throughput system for 3D EMT and metastatic 
breast cancer drug  screening 
Single spheroids cultured in 1536-well plates coated 
with MatrigelTM 
MDA-MB-231 breast carcinoma cells Li et al. (2011) 155 
Microfluidic chip for deterministic patterning of 
multicellular spheroids 
Chip coated with Pluronic copolymers that induce 
spheroid formation via cell aggregation 
SKOV3 ovarian cancer cells Kuo et al. (2012) 156 
Microfluidic system for 3D EMT monitoring and drug 
screening 
3D spheroid culture in collagen type I hydrogels 
integrated with co-culture of endothelial cell 
monolayer 
A549 lung carcinoma cells in co-culture 
with HUVECs 
Aref et al. (2013) 157 
3D culture of tumour cells and tumour biopsies for 
EMT study and personalized cancer therapy 
EMT inducing 3D nanofibrous scaffold of PLGA, PLA 
and methoxy PEG 
MCF-10A and MCF7 breast cancer cells; 
PC3 protate cancer cells; B16 melanoma 
cells; BG1 ovarian cells; LLC1 Lewis lung 
cancer cells 
Girard et al. (2013) 158 
Customized microfluidic platform to study flow 
induced EMT and metastasis 
3D nodules culture on growth-factor reduced Matrigel NIH:OVCAR5 ovarian cancer cells Rizvi et al. (2013) 159 
Complex 3D cell culture for lung cancer model Intestinal decellularized tissue matrix HCC827 and A549 lung carcinoma cells Stratmann et al. (2014) 160 
Microchip filter platform for isolation of 
heterogeneous population of cells with CTCs and 
EMT markers 
3D cell culture in ultralow adherent dishes for 
spheroid formation; 3D flow for cell separation in slit 
arrays via CAV1-EpCAM conjugated microbeads 
MDA-MB-231, MDA-MB-436, MCF-10A 
and SK-BR3 breast cancer cells; NCI-H1650 
and HCC 827 lung cancer cells; PC3 and 
LNCap prostate cancer cells 
Kim et al. (2014) 161 
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CHAPTER III 
Material and Methods 
The literature review provided on Chapter II identified several factors that must be taken in 
consideration when establishing an EMT/MET model based on 3D cell culture. Additionally, 
different methods have been described regarding the characterization of EMT/MET processes 
at the behavioural, cellular and molecular levels162. Therefore, this chapter describes the 
approach and methods used for the development of the 3D in vitro EMT/MET. 
1. 2D culture of EpH4 cells 
EpH4 cell line163 was maintained in normal culture medium constituted by Dulbecco’s Modified 
Eagle Medium with Glutamax (DMEM/F12 GlutaMAXTM, Gibco) supplemented with 5% v/v Fetal 
Bovine Serum (FBS, Biowest), 1% v/v Penicilin/Streptomycin (Pen/Strep, Gibco) and 5µg/mL 
Insulin solution human (10mg/mL; Sigma). Mesenchymal cells cultures were grown in normal 
culture medium supplemented with 8ng/mL of TGF-β1 recombinant human protein (Gibco) for 
7 days. For EMT reversion, mesenchymal cells were cultured for 4 days in normal culture 
medium. Cultures were maintained at 37°C in a 5% v/v CO2 humidified atmosphere in order to 
maintain physiological conditions. 
2. Alginate hydrogels preparation and formation 
Alginate hydrogels were prepared under cytocompatible and controlled conditions using RGD-
modified alginate at 1.7 and 2.7 wt-% in 0.9 wt-% sodium chloride (NaCl, Sigma). PRONOVA ultra-
pure alginate (FMC Biopolymers) with a molecular weight of 150kDa and a high glucuronic acid 
content (68%) was modified as previously described by Fonseca and colleagues164, by covalent 
grafting of the oligopeptidic sequence of (Glycine)4-Arginine-Glycine-Aspartic acid-Serine-
Proline (G4-RGDSP, Peptide International) performed by aqueous carbodiimide chemistry165. 
Alginate gelling process was accomplished by ionic crosslinking of alginate solution promoted by 
calcium166. For that purpose, alginate precursor solutions were homogeneously mixed with a 
suspension of calcium carbonate (CaCO3, Fluka) in 0.9 wt-% NaCl at a CaCO3/COOH molar ratio 
of 1.6, and the gelling process was triggered through the addition of a filtered (0.2µm) fresh 
glucose solution of delta-lactone (GDL, Sigma) in 0.9 wt-% NaCl at a CaCO3/GDL molar ratio of 
0.125. A final RGD-modified alginate concentration of 1 and 2 wt-% with 200µM of RGD is 
obtained by adding the previous solution to the cell suspension. In situ crosslinking (30min, at 
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37°C) was allowed after quickly applying small drops (14 and 20µL) of the mixture between 
Teflon plates separated by spacers with appropriate height (500 and 750µm, respectively); 
larger matrices – with 60µL of volume – were crosslinked within a QGelTM 3D disc caster device 
(QGel) that allows for the production of consistent and reproducible discs with high volume. 
After in situ crosslinking, the matrices were transferred to a 24-well culture plate (Falcon) coated 
with pHEMA (Sigma) and incubated with fresh culture medium at 37°C. The coating with pHEMA 
permanently reduces the adhesiveness of plastic tissue culture dishes167 which prevents cell 
migration from the hydrogels to the bottom of the wells. After 30-60min, the culture medium 
was changed accordingly to E, M and TS cell culture requirements.  
3. 3D culture of EpH4 cells within alginate-RGD hydrogels 
In order to immobilize the EpH4 cells within the RGD-modified alginate hydrogel, cells in 2D 
culture were harvested before reaching confluence through the incubation with 0.05% w/v 
trypsin/50mM ethylenediamine tetraacetic acid (EDTA) solution (Gibco) at 37°C, a solution that 
disrupts both cell-cell and cell-subtract adhesions. Trypsin/EDTA was inactivated with normal 
culture medium, and after centrifugation (1200rpm, 5min) and supernatant removal, EpH4 cells 
were ressuspended in 0.9 wt-% NaCl and homogeneously mixed, at the desired densities, with 
the alginate gel precursor and the crosslinking agents. After the crosslinking process, described 
in section 2, cells were kept at 37°C in a 5% v/v CO2 humidified atmosphere. Epithelial cultures 
were maintained in normal culture medium and mesenchymal cultures in normal culture 
medium supplemented with TGF- β1 recombinant human protein. 
4. Cell viability 
Cell viability under different 3D culture conditions was assessed by staining with Cytrak OrangeTM 
(1:200 dilution; Biostatus) and DRAQ7TM (1:1000; Biostatus) fluorescent dyes. Cytrak OrangeTM 
is a membrane-permeant dye that stains both nucleus and cytoplasm of live cells, whereas 
DRAQ7TM is a DNA counterstain that only stains the nuclei in dead or permeabilized cells. This 
live/dead staining was performed by incubating the cells cultured within the alginate-RGD 
hydrogels (height: 500µm; volume: 14µL) with the abovementioned fluorescent dyes for 10min 
at 37°C. Then, cells – within the hydrogel – were analyzed by confocal laser scanning microscopy 
(CLSM; Leica TCS-SP5 AOBS). Spheroid formation and morphology in the hydrogel were also 
analyzed through this 3D imaging. 
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5. Metabolic activity 
Cell metabolic activity was determined through a resazurin-based assay. To this end, hydrogels 
containing cells (height: 750µm; volume: 20µL; n=3) were incubated with 20% v/v of stock 
resazurin solution (0.1mg/mL, Sigma-Aldrich) in normal cell culture medium for 2h at 37°C and 
in the dark. After this incubation, 200µL of supernatant were transferred to a 96-well black plate 
(Greiner) and fluorescence measurements were performed using a microplate reader (Biotek 
Synergy MX) with excitation/emission at 530/590nm. Thereafter, samples were washed with 
Tris-buffered saline (TBS)/Calcium Chloride (CaCl2, 7.5mM, Merck) and EpH4 cells were retrieved 
from the alginate-RGD hydrogels for total protein quantification. The protein quantification was 
used to normalize data collected from the resazurin assay. Cell retrieval was accomplished by 
dissociating the matrix using 0.05% w/v trypsin/50mM EDTA solution, followed by centrifugation 
at 1200rpm for 5min. At that point, cells were washed with 1x Phosphate-Buffered Saline (PBS) 
and again centrifuged (1200rpm, 5min) with removal of supernatant. In order to promote cell 
lysis, cells were incubated with 1% v/v Triton X-100 (Sigma-Aldrich) for 1h at 250rpm and 4°C. 
After a 1:10 dilution in 1xPBS, PierceTM BCA Protein Assay Kit (Thermo Scientific) was used for 
quantification of total protein. Accordingly to manufacturer’s instructions, samples were 
transferred to a 96-well plate, mixed with the BCA working reagent and incubated for 30min at 
37°C, in the dark, to allow the colorimetric detection. Absorbance was measured at 540nm using 
a microplate reader. Absorbance was converted to µg/mL using a standard curve in the range of 
0-2000µg/mL.  
6. Transcriptional analyses by real-time PCR 
Gene expression quantification was performed by quantitative real-time polimerase chain 
reaction (real-time PCR). At each time point alginate-RGD hydrogels (height: 500µm; volume: 
20µL; n=3) were collected, washed with TBS/CaCl2 and cells were retrieved by dissolving the 
matrices using 0.05% w/v trypsin/50mM EDTA solution, followed by centrifugation (1200rpm, 
5min) and supernatant removal. Before cell pellet storage at -80°C until further analyses, cells 
were washed 3 times with 1xPBS. Total RNA was extracted using the mirVanaTM miRNA Isolation 
Kit (Ambion, Life Technologies), following the manufacturer instructions, and quantified by using 
NanoDropTM 1000 spectrophotometer (Thermo Scientific). For single stranded cDNA synthesis, 
1µg of total RNA was incubated during 10min at 70°C with random hexamer primers (0.1µg/µL) 
in DNase/RNase-free distilled water (Gibco), to prime reverse transcription reaction. After 2min 
on ice, a reaction mix containing 0.1M DTT (Invitrogen), 10mM dNTPs (Invitrogen), 8U RNase 
inhibitor (rRNasin® 40U/µL, Promega) and 150U reverse transcriptase (SuperScript®II 200U/µL, 
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Invitrogen) in 5x first-strand buffer (Invitrogen) was added to the samples for a final volume of 
20µL. Reverse transcription reaction was allowed via incubation at 37°C during 1h. Real-time 
PCR reaction mix was prepared on ice, by mixing the single stranded cDNA samples (50ng) with 
probes for target genes (0.5µL; Table 3) and master mix (5µL, TaqMan) in DNase/RNase-free 
distilled water for a final volume of 10µL. Samples were run in triplicates in the ABI Prism 7000 
Sequence Detection System and data was analysed by the comparative 2(-ΔΔCT) method168 and 
normalized to GAPDH. 
Table 3. Fluorescent probes for expression analysis of target genes by real-time PCR 
Marker Symbol Reference Supplier 
E-cadherin CDH1 Mm00486909 Applied Biosystems 
Occludin Ocln Mm.PT.47.16166845 Integrated DNA Technologies 
Mgat3 Mgat3 Mm00447798_s1 Applied Biosystems 
N-cadherin CDH2 Mm00483212_m1 Applied Biosystems 
Vimentin Vim Mm01333430_m1 Applied Biosystems 
ZEB2 Zeb2 Mm.PT.47.13169136 Integrated DNA Technologies 
Twist Twist Mm.PT.97.12853943 Integrated DNA Technologies 
Dies1 Dies1 Mm00472312_m1 Applied Biosystems 
ID2 Id2 Mm00711781_m1 Applied Biosystems 
ID3 Id3 Mm00492575_m1 Applied Biosystems 
GAPDH GAPDH 4352932-0912031 Applied Biosystems 
 
7. Immunocytochemistry analysis  
Immunocytochemistry was conducted to analyze the expression and cellular localization and 
organization of the epithelial marker E-cadherin (24E10 Rabbit mAb, #3195, Cell Signaling 
Technology), and mesenchymal markers Fibronectin (2755-8 Mouse mAb, #sc-69681, Santa Cruz 
Biotechnology) and α-SMA (Mouse mAb, #M0851, Dako), during EMT/MET induction. 
Immunocytochemistry was performed in alginate-RGD hydrogels (height: 500µm; volume: 14µL) 
that were collected at each time point, washed 3 times with TBS/CaCl2, fixed with 4% v/v 
Paraformaldehyde (PFA, Merck) with 7.5mM CaCl2 for 20min at RT and washed again. TBS was 
used instead of PBS since the presence of phosphate in PBS could sequester the calcium ions 
that maintain the ionic crosslinking of the hydrogels, which would induce a mechanical instability 
in the hydrogel169 that may lead to its degradation. Before the immunostaining, the alginate-
RGD hydrogels containing cells are incubated with 50mM Ammonium chloride (NH4Cl, 
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Calbiochem) in TBS/CaCl2 for 10min, and permeabilized with 0.2% Triton X-100 in TBS/CaCl2 for 
5min; both incubations were performed at RT and hydrogels were washed 3 times after each 
incubation. To block unspecific signal and enhance specific fluorescence, samples were 
incubated with 5% Bovine Serum Albumin (BSA, Fisher Scientific) in TBS/CaCl2 during 1h, and 
then incubated overnight at 4°C with primary antibodies in 5% BSA TBS/CaCl2. After the 
immunoreaction, samples were washed 3 times with TBS/CaCl2 and then incubated with 
secondary antibody Alexa Fluor® 594 Goat Anti-Rabbit (Life Technologies) and/or Alexa Fluor® 
488 Goat Anti-Mouse (Life Technologies) in TBS/CaCl2 for 2h in the dark. After washing 4 times 
with TBS/CaCl2, Vectashield® Mounting Media with DAPI (Vector Labs) was added to the 
samples. 3D imaging of the samples was accomplished by CLSM (Leica TCS-SP5 AOBS) and data 
analysis was performed using ImageJ software (http://rsb.info.nih.gov/ij/). 
8. 3D culture characterization 
For the characterization of spheroids geometry and number, alginate-RGD hydrogels were 
collected as described in section 7 and cell nuclei stained using Vectashield® Mounting Media 
with DAPI (Vector Labs). For image acquisition, hydrogels were transferred to a µ-Plate 96 well 
(ibidi) and the plate was read by an IN Cell Analyzer 2000 microscope (GE Healthcare). Bright 
field and fluorescence (excitation/emission for DAPI: 350/455nm) images were taken using a 
x10 objective lens and an advanced 2D deconvolution method with a 0.030 seconds exposition. 
Several fields were acquired in order to obtain images of the entire hydrogel. The obtained 
images were analyzed in the IN Cell Developer Toolbox software (GE Healthcare) that enables 
an individual characterization of each spheroid and their automatic counting. In order to 
improve spheroid recognition by the software, a protocol based on spheroid area, form factor, 
DAPI intensity and standard deviation of the signal was established. 
9. Population molecular characterization by Flow Cytometry 
Flow cytometry was carried out to assess the presence of E-cadherin, CD44 and CD29 antigens 
in the surface of EpH4 cells at different stages of EMT/MET. E-cadherin surface levels are 
critically reduced when cells are treated with peptidases commonly used for cell dissociation, 
such as trypsin, since E-cadherin mediated-intercellular adhesion is strongly dependent on 
calcium. Therefore, it is advisory the use of other cell dissociating agents such as Versene, a 
calcium-chelating agent. For this instance, alginate-RGD hydrogels (volume: 60µL; n=4) were 
collected at each time point and cells were retrieved using Versene (Gibco). After cell 
dissociation, cells were washed twice with 3%BSA in 1xPBS followed by centrifugation (1500rpm, 
5min, 4°C) and supernatant discard. Unspecific signal blocking was accomplished by incubation 
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with 3% BSA in 1xPBS for 30min on ice. Upon centrifugation (1500rpm, 5min, 4°C) and 
supernatant discard, samples were incubated with the conjugated antibodies diluted in 3% BSA 
in 1xPBS for 1h on ice in the dark. The conjugated antibodies used were: PE anti-mouse/human 
CD324 (BioLegend); PE anti-mouse CD44 (Miltenyi Biotec); APC anti-mouse CD29 (Miltenyi 
Biotec). For removal of unbinding antibody, samples were washed twice with 3% BSA in 1xPBS 
and fixed with 4% v/v PFA during 20min at RT. Samples were washed and resssuspended in 
1xPBS before running in the flow cytometer. Data was acquired using AccuriTM C6 Flow 
Cytometer (BD Biosciences) and data was analyzed using FlowJo software. 
10. Matrix metalloproteinases secretion by gelatin zymography 
To analyse the presence of secreted MMPs (MMP2 and MMP9), cell culture supernatants 
corresponding to the previous 24h of culture of each time point were collected (n=3), 
centrifuged at 1200rpm for 10min in order to remove cell debris and stored at -20°C for further 
analysis. Protein quantification was performed using the PierceTM BCA Protein Assay Kit (Thermo 
Scientific), as described in section 5, with a previous sample dilution of 1:4 in distilled water. For 
zymography, the preparation of 10% polyacrylamide gels containing 0.1% of gelatin as substrate 
(Table 4) and the electrophoresis were performed in a Mini-PROTEAN® Tetra Cell system (Bio-
Rad). Samples were prepared in order to load a final volume of 15µL, containing 5µL of Tris-
Sucrose SDS sample buffer and 10µL of sample diluted to yield 16µg or 32µg of total protein. 
Normal culture medium was used as a control. Electrophoresis was set at a constant voltage of 
80V in 1xTris-Glycine SDS running buffer (Bio-Rad), for one gel, and it was stopped when the 
25kDa marker of the Precison Plus Marker (Bio-Rad) runs out of the gel. Once the 
electrophoresis was complete, the gel was washed twice with 2% Triton X-100 for 15min on an 
orbital shaker to remove the SDS remnants, and incubated with MMP substrate buffer (50mM 
Tris-HCl, pH 7.5, 10mM CaCl2) for 16h at 37°C to allow the gelatin degradation by the MMPs. For 
zymogram development, the gel was washed with distilled water and incubated with 0.1% w/v 
Coomassie Brilliant Blue solution for staining. Thereafter, the gel was washed with distilled 
water, scanned using the GS-800 Calibrated Densiometer (Bio-Rad) and analysed through the 
QuantityOne software (Bio-Rad). 
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Table 4. Separating gel and Stacking gel preparation for MMPs analysis via in gel zymography 
Solution Separating gel* Stacking gel* 
Distilled water 1800µL 1020µL 
30% acrylamide-bisacrylamide (Bio-Rad) 1480µL 249µL 
10% SDS (Merck) 60µL 15µL 
1% gelatin (Sigma Aldrich) 600µL - 
0.5M Tris-HCl pH 6.8 - 189µL 
1.5M Tris-HCl pH 8.8 1500µL - 
10% APS (Sigma-Aldrich) 60µL 15µL 
TEMED (Sigma-Aldrich) 2.4µL 1.5µL 
*For preparation of 1gel 
11. Statistical Analysis 
Data are expressed as mean values of the independent experiments ± s.d., when more than one 
biological replica was analysed. Student’s t-tests were performed to determine statistically 
significant differences (* p < 0.05). 
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CHAPTER IV 
Results 
The central aim of this study was the generation of a 3D in vitro model of EMT/MET. As a cellular 
model we chose the near-normal mouse mammary EpH4 cell line, previously described as a 
nontumorigenic cell line163. This cell line was isolated from spontaneously immortalized mouse 
mammary gland epithelial cells, which means that they have not a fully normal phenotype, 
however the occurrence of unknown cellular features, such as mutations, rearrangements and 
even loss of chromosomes that could be seen as drivers of the outcomes of this model, should 
be reduced. Furthermore, EpH4 was already used in other EMT studies both for stable and 
transient inductions145,147,149,170–174. In our study, a transient EMT induction was accomplished 
using a classical inducer, TGF-β1, and MET was established by removing this stimulus from the 
cell culture environment. As mentioned in Chapter II, TGF-β1 is one of the most common EMT 
inducers used, mainly due to the high frequency of activation of TGF-β signalling pathway in 
cancer28. 
This chapter details the process of establishment of a 3D in vitro EMT/MET model, using ECM-
like hydrogels based on RGD-modified alginate, as described in chapter II. In addition, we also 
describe the additional studies performed on the previously established 2D in vitro EMT/MET 
model in order to complement the definition of its outcome. 
1. Complementary studies to characterize the 2D in vitro model of TGF-
β1-induced EMT/MET in EpH4 cell line 
 
The 2D TGF-β1-driven EMT/MET model in EpH4 cell line (Figure 6) was previously established 
and validated within our research group55. According to this model, for EMT induction, epithelial 
cells were cultured for 7 days in normal culture medium supplemented with TGF-β1, which 
allowed cells to acquire a mesenchymal-like phenotype (2D-M7 cells). The mesenchymal nature 
of these cells was further confirmed by the de novo expression of several mesenchymal markers. 
As a biological control, epithelial cells were grown without TGF-β1 supplementation for 7 days 
(2D-E7 cells). The reverse process, MET, was achieved by culturing the 2D-M7 cells in normal 
culture medium, without TGF-β1 supplementation, for another 4 days (2D-TS11 cells). Cells 
resulting from this reversion revealed a heterogeneous phenotype that although displaying an 
overall reacquisition of an epithelial-like phenotype, retained differential expression of some 
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mesenchymal markers. This population was named TS cells as they resemble a “transient state” 
phenotype between epithelial and mesenchymal cells (unpublished data). 
 
Figure 6. Representation of the 2D in vitro TGF-β1-driven EMT/MET induction. For EMT induction cells 
were cultured for 7 days in normal culture medium supplemented with 8 ng/mL of TGF-β1 – 2D-M7 cells. 
For MET induction, cells were cultured 7 days with TGF-β1 (8ng/mL) followed by 4 days without TGF-β1 
supplementation – 2D-TS11 cells. Epithelial cells (2D-E7 cells), the biological control, were seeded at the 
same density and cultured during the same period of time as 2D-M7 cells, without TGF-β1 
supplementation.  
 
Several studies concerning expression at the RNA level of epithelial/mesenchymal markers, as 
well as functional assays, were previously performed by our research group, in order to 
characterize the 2D-E7, M7 and TS11 cells (data not shown). To further complement the 
characterization of the 2D in vitro model of EMT/MET induction, we measured the proportion 
of 2D-E7, 2D-M7 and 2D-TS11 cells that were positive for CD29 and CD44 markers by flow 
cytometry. Together these markers are able to identify cell sub-populations with stem 
properties, a feature known to be associated with EMT induction72.  We observed that 2D-M7 
cells were enriched in CD29+/CD44+ subpopulation in comparison to the 2D-E7 epithelial control 
(41.8% and 35.4% respectively, p=0.4194). Moreover, the CD29+/CD44+ subpopulation was 
significantly reduced in 2D-TS11 (17.4%, p=0.0246) (Figure 7A), supporting the occurrence of 
EMT reversion. The enrichment in CD29+/CD44+ cells in 2D-M7 appeared to be associated with 
the gain of a subpopulation that highly expressed CD44 (p=0.0716), which was lost in the 2D-
TS11 cells (Figure 7B). Indeed, 2D-TS11 cells accumulated not only a significant decrease of 
CD44+ cells (p=0.1152) but also a reduction of CD29+ cells (p=0.429). 
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Figure 7. CD29 and CD44 expression during EMT/MET induction in the 2D in vitro model. Flow cytometry 
was used to determine the expression of CD29 (integrin-β1) and CD44 in EMT-derived cells (2D-M7) and 
MET-derived cells (2D-TS11), compared to the epithelial control (2D-E7). A. CD29/CD44 double-staining. 
B. CD29 and CD44 single-staining for 2D-E7 (red), 2D-M7 (blue) and 2D-TS11 (orange) populations. Results 
were described as mean ± standard error of two biological replicas. Single asterisk corresponded to p≤0.05 
and ns corresponded to non-significant changes. 
 
Next, we evaluated the ability of cells at different stages of the EMT/MET process to secrete 
MMP2 and MMP9, also known as gelatinase A and B, respectively. The results showed an 
increase of MMP9 expression in 2D-M7 (1.75-fold) compared to the epithelial control (2D-E7) 
(Figure 8). Furthermore, in 2D-TS11 cells, the basal levels of MMP9 were almost fully recovered 
(1.13-fold), in agreement with reversion to an epithelial-like phenotype. Regarding MMP2 
expression, no significant variations were recorded, however it was possible to identify a slight 
increase both in 2D-M7 and 2D-TS11 cells. Together these results indicated that expression of 
MMP9 but not MMP2, was induced during EMT in this 2D model. 
 
Figure 8. Effect of EMT/MET induction on MMP2 and MMP9 secretion. Relative quantification was 
performed to basal level expressed by epithelial cells (2D-E7). 32ug of total protein were loaded for each 
sample. (n=1 biological replica) 
A. 
ns 
* 
ns ns 
ns ns 
B. 
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2. Establishment of a 3D in vitro model of TGF-β1-induced EMT/MET in 
EpH4 cell line using ECM-like hydrogels 
The 3D model reported on this document derived from the 2D in vitro model previously 
established, as it makes use of the same cell type – EpH4 cell line – and the same method for 
transient EMT/MET induction, TGF-β1 supplementation to the culture medium. In order to build 
a well-defined 3D system, RGD-modified alginate hydrogels were used as an artificial ECM-like 
matrix for 3D in vitro culture108. 
2.1  Definition of the 3D in vitro culture conditions 
In order to determine the best culture conditions to study the EMT/MET process, EpH4 cells 
were cultured for 14 days in normal culture media (3D-E14) within RGD-modified alginate 
hydrogels with different concentrations (1 and 2 wt-%) and at different cell densities (5x106 and 
10x106 cells/mL). 
We assessed the viability of EpH4 cells in the 3D environment through a live/dead staining and 
we observed that the majority of cells was viable in all conditions tested (Figure 9). The best 
scenario, i.e diminished presence of dead cells, was found when cells were cultured in the 1 wt-
% RGD-alginate hydrogels (Figure 9A and 9B). Additionally, it was observed that when cells were 
seeded at a density of 5x106 cells/mL in 1 wt-% RGD-alginate hydrogels, larger sized spheroids 
were detected in comparison with the corresponding higher density condition (Figure 9A and 
9B). Moreover, in the 1 wt-% RGD-alginate hydrogels, cells cultured in a density of 10x106 
cells/mL (Figure 9B) formed what seems to be a monolayer in the surface of the hydrogel in 
addition to the matrix-embedded spheroids. In accordance with these results, 1 wt-% RGD-
alginate hydrogels and cell density of 5x106 cells/mL was the best option for culturing EpH4 cells 
in a 3D in vitro environment, enabling the formation of large spheroids with very high cell 
viability. Therefore, we chose these conditions to perform the subsequent tests. 
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Figure 9. Effect of the 3D in vitro environment on cell viability using the Cytrak OrangeTM/DRAQ7TM 
live/dead staining. Immunofluorescence of 3D-E14 cells cultured in 1 wt-% RGD alginate hydrogels (A, B) 
and in 2 wt-% RGD alginate hydrogels (C, D) with a cell density of 5x106 cells/mL (A, C) or 10x106 cells/mL 
(B, D). Live cells were shown in green and dead cells in red. The scale bar corresponded to 100µm. 
 
2.2 Characterization of the EpH4 cell line behaviour in the RGD-alginate hydrogel model 
To better understand the EMT induced phenotype it was important to assess whether EpH4 cells 
maintained an epithelial behaviour in the selected 3D culture system. For that purpose, EpH4 
cells at a cell density of 5x106 cells/mL, were cultured in the 1 wt-% RGD-alginate hydrogels with 
normal culture medium and monitored for 21 days both at RNA and protein level. Additional 
studies regarding the metabolic activity and spheroid morphology were also performed. 
The measurement of the metabolic activity (resazurin-based method) showed that the overall 
metabolic activity of cells in each hydrogel disk increased with time reaching a 2.62-fold increase 
at day 21 (3D-E21 cells in comparison with 3D-E3 cells, Figure 10A). Regarding spheroid 
morphology, although there was a decrease in spheroid number (Figure 10B), an increase in 
spheroid area was observed (Figure 10C). 
 
Figure 10. Morphological and metabolic characterization of EpH4 spheroids in the 1wt-% RGD-alginate 
hydrogels. A. Metabolic activity of cells embedded within the hydrogels (n=3 independent hydrogel disks 
in each time-point). B. Number of spheroids and C. Spheroid area measured in the best confocal plan and 
plans immediately above and below, using the same acquisition and segmentation strategy in all disks 
(n=1 hydrogel disk in each time-point). Data was normalized for 3D-E3 in each assay. 
A. B. C. D. 
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Epithelial and mesenchymal markers, respectively E-cadherin and α-SMA, were assessed during 
the 3D culture in order to characterize phenotypic changes at protein level. We observed E-
cadherin staining at the cell membrane in 3D-E7 cells, while little or no expression was detected 
in 3D-E3 cells (Figure 11A and 11D). E-cadherin staining at the cell membrane was also detected 
in all other time-points analysed, from 3D-E10 to 3D-E21 (Figure 11G, 11J, 11M and 11P). 
Regarding the α-SMA staining, no expression was detected both in 3D-E3 and 3D-E7 cells (Figure 
11B and 11E). Nevertheless, in 3D-E10, 3D-E14, 3D-E17 and 3D-E21 cells, expression of this 
marker was detected (Figure 11H, 11K, 11N and 11Q). Interestingly, we noticed that when E-
cadherin and α-SMA co-localized in the same spheroid, the area in which α-SMA is expressed 
displayed a weaker, and in some cases cytoplasmic E-cadherin staining, suggesting functional 
impairment (Figure 11L, 11O and 11R).  
To complement these studies, we addressed the secretion of MMPs by EpH4 cells across time. 
However, no changes both in MMP9 and MMP2 expression were observed (Figure 12). 
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Figure 11. Assessment of the expression of epithelial and mesenchymal markers in 3D epithelial 
cultures. Co-immunofluorescence for E-cadherin (red) and α-SMA (green) in 3D-E3 cells (A-C), 3D-E7 cells 
(D-F), 3D-E10 cells (G-I), 3D-E14 cells (J-L), 3D-E17 cells (M-O) and 3D-E3 cells (P-R). Merged images 
illustrated the presence of E-cadherin at the membrane since day 7 in culture (F, I, L, O, R) and the gain 
of α-SMA expression after 14 days in culture (L, O, R). The scale bar corresponds to 50µm. 
A. B. C. 
D. E. F. 
G. H. I. 
J. K. L. 
M. N. O. 
P. Q. R. 
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Figure 12. MMP secretion profile of EpH4 cells cultured in the 3D in vitro system. MMP2 and MMP9 
secretion. Relative quantification was performed to normal culture medium (CM). 16ug of total protein 
were loaded for each sample (n=2 biological replicas). 
 
Next, we analysed the RNA extracted from the cell populations obtained across time (Figure 13), 
in order to assess transcriptional modifications that occurred in EpH4 3D-E cells. Given that very 
few cells were obtained at day 3 (3D-E3), no markers were assessed for this time-point. For all 
subsequent comparisons, expression levels of 3D-E7 cells were used for normalization purposes. 
We observed that E-cadherin coding gene, CDH1, was slightly upregulated in 3D-E10 cells, with 
a 1.3-fold increase in comparison with 3D-E7 cells, the first time-point assessed in which we also 
had observed E-cadherin staining at the cell membrane. However, in 3D-E17 and 3D-E21 cells, 
CDH1 was found to be strongly downregulated, with a 0.4 and 0.1-fold decrease in comparison 
with 3D-E7 cells, respectively (Figure 11). For the epithelial marker Ocln (Occludin), we observed 
a marked increased expression in 3D-E10 cells, both in comparison with 3D-E7 and 3D-E14. Due 
to technical problems, Ocln expression could not be assessed in 3D-E17 and 3D-E21 cells. For 
the mesenchymal marker, CDH2 (N-cadherin), a wave-like expression pattern was detected: we 
observed an increased expression (1.6-fold) in 3D-E10 cells, which was later abrogated in 3D-
E14 cells (0.9-fold). Afterwards, CDH2 expression was again increased in 3D-E17 cells (2.3-fold) 
and later abolished in 3D-E21 (0.7-fold). In turn, the mesenchymal marker Vim (Vimentin), 
presented a slightly different pattern since no variations were found until day 14 (3D-E14 cells); 
still, in 3D-E17 cells a peak in the expression of this marker was detected (4.1-fold) but such 
expression was reduced in 3D-E21 cells (1.9-fold). We further complemented this analysis by 
assessing the expression of genes that encode for two transcriptional factors involved in the 
EMT induction, ZEB2 and Twist1175. We observed that ZEB2 was downregulated in 3D-E14 cells 
(0.5-fold) and upregulated in 3D-E17 (2.3-fold), being this increased expression abolished in 3D-
E21 cells (0.5-fold) in a perfect correlation with the results obtained for both mesenchymal 
markers assessed. We did not find any significant variations concerning Twist1 expression. 
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Figure 13. RNA signature of EpH4 cells cultured in the 3D in vitro system. n=1, and 3 technical replicates 
used for each measurement. Data was normalized to 3D-E7. Due to technical problems, Ocln expression 
could not be assessed in 3D-E17 and 3D-E21 cells. 
 
Overall, these results showed that EpH4 cells displayed a stable epithelial phenotype until day 
14 (3D-E14). In addition, we observed that longer periods of 3D culture of these cells could 
induce changes in the expression of epithelial and mesenchymal markers, both at RNA and 
protein levels.  
 
2.3 Characterization of EMT induction in EpH4 cells cultured in the RGD-alginate hydrogel 
model 
For EMT induction, we cultured EpH4 cells at 5x106 cells/mL in a 1wt-% RGD-alginate hydrogels 
in the presence of TGF-β1 (16 ng/mL) during 3, 7, 10 and 14 days, thus generating 3D-M3, 3D-
M7, 3D-M10 and 3D-M14 cell populations and assessed several cellular features (Figure 14). 
 
Figure 14. Representation of the 3D in vitro TGF-β1-driven EMT. For EMT induction, EpH4 parental cells 
(2D) were cultured for up to 14 days with TGF-β1 supplementation. Cells were harvested at day 3 (3D-M3 
cells), day 7 (3D-M7 cells), day 10 (3D-M10 cells) and day 14 (3D-M14 cells) to assess EMT associated 
features. Epithelial cells (3D-E3, 3D-E7, 3D-E10 and 3D-E14) were cultured in the same conditions, without 
TGF-β1 supplementation.  
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Firstly, we measured the metabolic activity of each cell population and observed that it was 
consistently decreased during the period of culture analysed (Figure 15A and 15B). In fact, the 
metabolic activity decreased approximately 30% in 3D-M10 and 3D-M14 cells, in comparison to 
3D-M3 cells (Figure 15B).  As we compared the metabolic rates of 3D-M cells with the 
corresponding 3D-E cells, we observed that in the initial phase of culture the metabolic rate was 
very similar for both cell types, as seen for day 3 and day 7 (3D-M3 vs. 3D-E3; 3D-M7 vs. 3D-E7). 
However, for longer periods of TGF-β1 treatment, the difference in metabolic activity between 
3D-M and 3D-E cells started to be noticeable. In fact, both 3D-M10 and 3D-M14 cells displayed 
a massive decrease in metabolic rate when compared with the respective biological controls, 
3D-E10 and 3D-E14 cells (0.4-fold decrease, Figure 15C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Metabolic activity during EMT induction. A-B. EpH4 cells cultured in the 3D in vitro system in 
normal culture medium supplemented with TGF-β1 (16 ng/mL). (A) Raw values of metabolic activity in 
relative fluorescence units (RFU) (B) Data normalized to 3D-M3 cells. C. Comparison between epithelial 
and mesenchymal cultures. Data normalized to correspondent epithelial control cells. n=1, technical 
triplicates for independent hydrogel disks in each time-point. 
 
To evaluate the EMT phenotype during the time of induction – at protein level – we assessed 
the expression of E-cadherin and α-SMA by co-immunostaining, and MMPs secretion. 
Concerning E-cadherin, we observed an overall decreased membrane staining, however never 
was complete loss of expression protein observed in any of the analysed days. In fact, 3D-M3 
and 3D-M7 cells (Figure 16A and 16D) revealed a weaker expression of this epithelial marker, 
which was detected in the cytoplasm of cells rather than in the cell membrane, suggesting 
functional impairment. This cytoplasmic delocalization of E-cadherin was also observed in 3D-
M10 (Figure 16G) and 3D-M14 (Figure 16J), although with increased expression levels when 
compared to 3D-M3 and 3D-M7 cells. In addition, 3D-M14 displayed increased presence of E-
cadherin at cell membrane. Regarding the mesenchymal marker α-SMA, its expression was 
A. B. 
C. 
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detected in all samples analysed: while in 3D-M3 cells the expression detected was weak (Figure 
16B), it became stronger in 3D-M7, 3D-M10 and 3D-M14 cells (Figure 16E, 16H and 16K). 
Concerning MMPs, both MMP9 and MMP2 secretion was not altered during this experiment 
and the only variations found indicated a slight increase of MMP2 secretion (Figure 17A). When 
comparing these results with the MMP secretion by the corresponding 3D-E cells, no relevant 
differences were observed and the only trend found was a small increase in MMP2 secretion 
across all 3D-M cells (Figure 17B). 
 
Figure 16. Assessment of the expression of epithelial and mesenchymal markers in 3D mesenchymal 
cultures. Co-immunofluorescence for E-cadherin (red) and α-SMA (green) in 3D-M3 cells (A-C), 3D-M7 
cells (D-F), 3D-M10 cells (G-I) and 3D-M14 cells (J-L). Merged images illustrate the presence and 
localization of E-cadherin and α-SMA during the 14 days of culture. The scale bar corresponds to 50µm. 
A. B. C. 
D. E. F. 
G. H. I. 
J. K. L. 
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Figure 17. MMP secretion profile of EpH4 cells cultured in the 3D in vitro system in normal culture 
medium supplemented with TGF-β1. A. MMP2 and MMP9 secretion. Relative quantification was 
performed to normal culture medium (CM). 32ug of total protein were loaded for each sample. B. 
Comparison of MMP secretion in epithelial and mesenchymal cultures. Data was normalized to the normal 
culture medium run in each experiment. n=1 biological replica 
 
The abovementioned changes were further explored by quantification of the RNA expression of 
the same epithelial and mesenchymal markers, as well as ZEB2 and Twist1 (Figure 18).  No 
information could be collected concerning 3D-M3 cells due to lack of biological material. 
Concerning CDH1 expression, we observed that all 3D-M cell populations displayed increased 
levels of this epithelial marker than the equivalent 3D-E cells. When focusing only in the 3D-M 
populations (normalized to the corresponding 3D-E cells), we observed that 3D-M10 cells 
displayed the highest levels of CDH1 (8.09-fold in comparison with 3D-E10 cells). Concerning 
Ocln, the lowest levels of expression were detected in 3D-M10 cells (0.48-fold in comparison to 
3D-E10 cells). However this downregulation may be an artefact due to the previously detected 
increase in Ocln expression in 3D-E10 cells. Regarding CDH2, Vim and Zeb2, all 3D-M cells 
revealed a consistent increased expression in comparison with the corresponding 3D-E cells, in 
agreement with acquisition of mesenchymal properties (ranging from 1.86 to 9.52-fold). 
Concerning Twist1, only 3D-M7 cells displayed increased expression of Twist1 comparing with 
the respective 3D-E7 cells (1.51-fold). For both 3D-M10 and 3D-M14, Twist1 expression was 
below or at the same levels as observed in 3D-E10 and 3D-E14, respectively (0.46 and 1.06-fold). 
A. 
B. 
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Similarly to Ocln, 3D-E10 cells displayed an increased expression of Twist1 in comparison with 
3D-E7 cells (1.40-fold), hampering the observations made for Twist1 expression in 3D-M10. 
 
Figure 18. RNA signature of 3D-M cells and comparison to epithelial RNA profile. N=3 replicates were 
used for each measurement. Data for 3D-M cells was normalized to the corresponding 3D-E cells (3D-M7 
vs. 3D-E7, 3D-M10 vs. 3D-E10, 3D-M14 vs. 3D-E14). Data for 3D-E cells was normalized to 3D-E7 cells. 
 
Altogether, these findings suggested that both 3D-M7 and 3D-M14 cells already display a 
mesenchymal-like phenotype.  However, while 3D-M7 cells displayed E-cadherin functional 
impairment, as suggested by its cytoplasmic localization, in 3D-M14 cells, E-cadherin was 
present at cell membrane. Moreover, CDH2, Vim and ZEB2 expression was enhanced in 3D-M7 
and 3D-M14 as was α-SMA expression, all of which hallmarks of mesenchymal/EMT cells. 
Despite these similarities, we selected 3D-M7 cells as the end-point of our 3D EMT induction, 
due to the observed differential E-cadherin cellular localization. 
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2.4 Characterization of MET induction in EpH4 cells cultured in the RGD-alginate hydrogel 
model 
As previously mentioned, when MET was induced in the 2D in vitro model developed by our 
research group, a “transient-state” population was obtained, with simultaneous expression of 
epithelial and mesenchymal markers and an overall epithelial-like. In order to assess the 
behaviour of the same cell line in the 3D in vitro model upon MET induction, EpH4 3D-M7 cells 
(7 days with TGF-β1) were further cultured without TGF-β1 supplementation. Metabolic activity, 
MMPs secretion, E-cadherin/α-SMA co-immunostaining and RNA expression of epithelial and 
mesenchymal markers was assessed in two time-points: 3 and 7 days post-TGF-β1 removal from 
the culture system (3D-TS10 and 3D-TS14, respectively, Figure 19). 
 
Figure 19. Representation of the 3D in vitro TGF-β1-driven EMT/MET induction. For MET induction, 3D-
M7 cells were cultured for up to 7 days without TGF-β1 supplementation. Cells were harvested at day 10 
(3 days post-TGF-β1 removal, 3D-TS10 cells) and day 14 (7 days post-TGF-β1 removal, 3D-TS14 cells) to 
assess MET associated features. Epithelial cells (3D-E7, 3D-E10 and 3D-E14) were cultured in the same 
conditions, without TGF-β1 supplementation.  
 
Firstly, we measured the number and size of spheroids and we found that 3D-M7 (EMT-induced 
cells) disks presented higher number of spheroids (Figure 20A), although with smaller size 
(Figure 20B), compared to the epithelial control 3D-E7 (1678 spheroids with average size of 
349.2µm2 vs. 1285 spheroids with average size of 645.6µm2, respectively). A similar scenario 
also occurred when comparing 3D-TS10 with 3D-E10 (1656 spheroids with average size of 
473.4µm2 vs. 1422 spheroids with average size of 856.5µm2). Interestingly, 3D-M7 spheroids 
(size and number) were similar to those observed in 3D-TS10 cells. We also observed that 
despite a similar average size, 3D-TS14 cells displayed a diminished spheroid number than both 
3D-M7 and 3D-TS10 cells (1058 spheroids vs. 1678 and 1656 spheroids, respectively). These 
results suggest that MET might be inducing a change on spheroid growth, potentially by 
increasing proliferation. To address this question we measured the metabolic rate of these cells 
and observed that all 3D-E cells (3D-E7, 3D-E10 and 3D-E14) exhibited higher levels of metabolic 
activity than the corresponding 3D-M/TS cells (Figure 20C). While 3D-M7 cells displayed a 50% 
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decrease in metabolic rate in comparison with 3D-E7 cells, both 3D-TS10 and 3D-TS14 seemed 
to recover their metabolic activity to levels closer to those registered for their counterparts 
(0.59-fold for 3D-TS10 and 0.73-fold for 3D-TS14, Figure 20C). These observations also support 
that MET might be inducing cell proliferation or at least a metabolic change in 3D-TS10 and 3D-
TS14 cells.  
Given that the number of cells in each hydrogel disk might significantly impact the metabolic 
activity measured, we decided to normalize the abovementioned values to the total protein 
content (Figure 20D). This rationale assumed that protein content was directly proportional to 
the total cell number. In fact, the measured protein content increased steadily from 3D-M7 up 
to 3D-TS14, as did the respective epithelial controls (Figure 20D). Upon normalization, we 
observed that, unlike all the previous results, there was a decrease in normalized metabolic 
activity in both 3D-E10 and 3D-E14 cells in comparison to 3D-E7 cells (Figure 20E). Moreover, 
3D-TS10 cells were more active in terms of normalized metabolic rate, than the corresponding 
3D-E10 cells (2.70-fold increase in 3D-TS10 cells, Figure 20E). Finally, 3D-TS14 cells displayed a 
similar normalized metabolic activity comparing with 3D-E14 cells (0.86-fold decrease in 3D-
TS14, Figure 20E). 
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Figure 20. Morphological and metabolic characterization of EMT/MET populations obtained in the 3D 
in vitro system. A. Number of spheroids and B. Spheroid area measured in the best confocal plan and 
plans immediately above and below, using the same acquisition and segmentation strategy in all disks 
(n=1 hydrogel disk in each time-point). C. Metabolic activity of cells embedded within the hydrogels. Data 
normalized to correspondent epithelial control cells. D. Cellular protein content of different cell types 
(µg/mL). E. Metabolic activity of cells embedded within the hydrogels normalized with protein content. 
Data normalized to correspondent epithelial control cells. n=1, technical triplicates for independent 
hydrogel disks in each time-point. 
 
The evaluation of MMP secretion revealed that 3D-TS10 and 3D-TS14 cells tend to secrete higher 
amounts of MMP9 in comparison to 3D-M7 (Figure 21A). Furthermore, 3D-TS14 cells also 
secreted more MMP2 than both 3D-TS10 and 3D-M7 cells. When comparing to the 
corresponding 3D-E cells, we observed that 3D-TS14 cells secreted higher levels of MMP9 and 
MMP2, while 3D-TS10 cells only showed this increased secretion for MMP9 (Figure 21B). 
E. 
A. 
B. 
C. D. 
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Figure 21. MMP secretion profile during EMT/MET in EpH4 cells cultured in the 3D in vitro system. A. 
MMP2 and MMP9 secretion. Relative quantification was performed to normal culture medium (CM). 32ug 
of total protein were loaded for each sample (n=1 biological replica). B. Comparison of MMP secretion 
during EMT/MET induction and in epithelial cultures. Data was normalized to the normal culture medium 
run in each experiment. 
 
By immunostaining, we assessed the presence of E-cadherin and observed that this marker was 
strongly expressed at the cell membrane in 3D-E7, 3D-E10 and 3D-E14 (Figure 22A, 22G, 22M), 
as described in previous experiments. Again, 3D-M7 cells expressed low levels of E-cadherin 
which was mainly localized at the cytoplasm of the cells (Figure 22D). In 3D-TS10 and 3D-TS14 it 
was possible to observe an increase in E-cadherin expression, particularly in 3D-TS14 cells. 
Indeed, in 3D-TS10 cells E-cadherin seems to be mostly localized in the cytoplasm (Figure 22J), 
while in 3D-TS14 cells we observed a heterogeneous pattern, since in some spheroids E-cadherin 
was localized in membrane and in others in the cytoplasm (Figure 22P). Regarding the α-SMA 
marker, almost no expression was detected in 3D-E7 cells (Figure 22B), however in 3D-E10 and 
3D-E14 samples some spheroids were found to exhibit expression of this marker (Figure 22H 
and 22N). We also observed expression of α-SMA in 3D-M7, 3D-TS10 and 3D-TS14 spheroids 
(Figure 22E, 22K and 22Q), although this expression seemed to be decreased in 3D-TS10 cells. 
A. 
B. 
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Figure 22. Assessment of the expression of epithelial and mesenchymal markers during EMT/MET 
induction in EpH4 cells cultured in the 3D in vitro system. Co-immunofluorescence for E-cadherin (red) 
and α-SMA (green) in 3D-E7 cells (A-C), 3D-M7 cells (D-F), 3D-E10 cells (G-I), 3D-TS10 cells (J-L), 3D-E14 
cells (M-O) and 3D-TS14 cells (P-R). The scale bar corresponds to 50µm. 
 
Additionally, we measured the presence of CD29 and CD44 in the membrane of these cells by 
flow cytometry. We observed a decrease in the CD29+/CD44+ subpopulation in 3D-TS10 and 3D-
TS14 cells both comparing with 3D-M7 cells and the epithelial counterparts (Figure 23A). In 
addition, 3D-TS14 cells displayed a smaller CD29+/CD44+ subpopulation than 3D-TS10 cells 
A. B. C. 
D. E. F. 
G. H. I. 
J. K. L. 
M. N. O. 
P. Q. R. 
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(17.8% vs. 30.4%), similarly to their epithelial counterparts (23.9% for 3D-E14 and 44.6% for 3D-
E10). Interestingly, the difference between 3D-TS14 and 3D-E14 (6.1% decrease in 3D-TS14 cells) 
was less than half of the difference between 3D-TS10 and 3D-E10 (14.2% decrease in 3D-TS10 
cells). These results pinpointed the pair 3D-TS14/3D-E14 cells as more similar than 3D-TS10/3D-
E10 cells. Considering the 3D-E10/3D-TS10 counterparts, the decrease of the CD29+/CD44+ 
population was due to the decrease of CD44+ cells whereas in 3D-E14/3D-TS14 cells, the 
reduction of the double positive population was due to a concomitant decrease of both CD29+ 
and CD44+ cells (Figure 23B). No relevant changes were reported for 3D-M7 comparing to 3D-
E7. Moreover, we analysed the percentage of E-cadherin positive cells in these populations and 
verified that the presence of E-cadherin at the cell membrane was reduced in 3D-M7, 3D-TS10 
and 3D-TS14 cells comparing to 3D-E7, 3D-E10 and 3D-E14, respectively (Figure 23B). 
Notwithstanding, the percentage of positive E-cadherin cells was low in all samples analysed, 
even in 3D-E7, 3D-E10 and 3D-E14 epithelial cells (ranging from 17.8% to 43.2% of E-cadherin 
membrane-positive cells). 
We further investigated RNA expression of the markers used in the aforementioned 
experiments. In addition, we analysed the expression of Mgat3, ID2 and ID3 given they have 
been associated with MET induction in the 2D in vitro EpH4 model. Mgat3 has been shown to 
be downregulated with EMT and upregulated with MET (similarly to an epithelial marker55) while 
both ID2 and ID3 were upregulated in EpH4 2D-MET (unpublished work by our research group).  
We started by comparing the RNA expression levels of all epithelial and mesenchymal markers 
in 3D-TS10 and 3D-TS14 cells against 3D-M7 cells, to understand the TGF-β1 removal effect (MET 
induction, Figure 24). We observed that CDH1 expression was slightly diminished in 3D-TS10 
cells and exhibited a trend for upregulation in 3D-TS14 cells (0.85 and 1.31-fold respectively). 
Concerning Ocln, its expression levels were increased only in 3D-TS14 cells (1.06 and 1.26-fold 
increase respectively). CDH2 and Vim were found to be downregulated in 3D-TS14 (0.62 and 
0.37-fold); in fact, Vim was already decreased in 3D-TS10 cells (0.56-fold). ZEB2 was 
downregulated both in 3D-TS10 and 3D-T14 comparing to 3D-M7 cells, displaying a higher 
decrease in the 3D-TS10 cells (0.38 and 0.74-fold). In contrast, Twist1 expression did not change 
in 3D-TS10 and increased in 3D-TS14 cells (1.02 and 1.72-fold). Mgat3 exhibited a pattern similar 
to ZEB2, being downregulated in 3D-TS10 cells but recovering, in 3D-TS14 cells to the same 
expression level detected in 3D-M7 cells (0.26 and 0.97-fold). Finally, ID2 and ID3 showed a 
parallel upregulation in 3D-TS14 cells (1.48 and 1.19-fold), however in 3D-TS10 the behaviour of 
these markers was different, with ID2 being upregulated and ID3 downregulated (1.97 and 0.84-
fold). 
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Figure 23. E-cadherin, CD29 and CD44 expression during EMT/MET induction in the 3D in vitro system. 
Flow cytometry was used to determine the expression of E-cadherin, CD29 (integrin-β1) and CD44 in EMT-
derived cells (3D-M7) and MET-derived cells (3D-TS10 and 3D-TS14), compared to the epithelial controls 
(3D-E7, 3D-E10 and 3D-E14). A. CD29/CD44 double-staining. B. E-cadherin, CD29 and CD44 single-staining 
for 3D-E7 (red), 3D-M7 (blue) and 2D-TS11 (orange) populations. n=1, four independent technical 
replicates for each time-point. 
A. 
B. 
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Summarizing, 3D-TS10 cells were characterized by a strong downregulation of Vim, ZEB2 and 
Mgat3 and an increase of ID2. On the other hand, 3D-TS14 cells were characterized by a 
decreased expression of CDH2 and Vim, concomitantly with an increase of Twist1. For this 
characterization we considered that a gene upregulated for RNA expression increase over 1.5-
fold, and downregulated for a decrease below 0.66-fold. 
 
 
Figure 24. RNA signature of cells undergoing EMT/MET in the 3D in vitro system. N=3 replicates were 
used for each measurement. Data was normalized to 3D-M7 cells. 
 
Finally, to understand how similar 3D-TS10 and 3D-TS14 cells were to epithelial cells, thus 
unveiling the reversibility of our 3D-EMT/MET model, we compared the RNA expression levels 
of all epithelial and mesenchymal markers in 3D-TS10 and 3D-TS14 cells against 3D-E7 cells, 
(Figure 25). Concerning CDH1 and Ocln, 3D-M7, 3D-TS10 and 3D-TS14 cells displayed increased 
expression in comparison with 3D-E7 cells, however only 3D-TS14 cells showed a relevant 
upregulation of CDH1 (1.57-fold). For 3D-M7 cells we observed an upregulation of all 
mesenchymal markers assessed (CDH2, Vim, ZEB2 and Twist1, ranging from 1.23 to 7.38-fold), 
later on abrogated (Vim and ZEB2, 4.11 and 1.45-fold) or stabilized (CDH2 and Twist1, 2.57 and 
1.25-fold) in 3D-TS10 cells. Concerning Mgat3, ID2 and ID3, 3D-M7 cells showed an overall 
downregulation (0.38, 0.43 and 0.67-fold). In 3D-TS10 cells, both Mgat3 and ID3 continued to 
decrease (0.10 and 0.56-fold) while ID2 expression recovered to levels closer to 3D-E7 cells 
(0.85-fold). In 3D-TS14 cells, Mgat3 and ID3 expression increased to levels equal or above those 
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registered in 3D-M7 cells (0.37 and 0.80-fold), however ID2 expression decreased (0.64-fold) 
although still at levels above 3D-M7 cells. 
 
Figure 25. RNA signature of cells undergoing EMT/MET in the 3D in vitro system. N=3 replicates were 
used for each measurement. Data was normalized to 3D-E7 cells. 
 
Overall, these results suggested that a partial MET was obtained in 3D-TS10/3D-TS14 cells. In 
both cell types, upregulation of MET-associated genes ID2 and ID3, residual to low expression 
of α-SMA and decreased presence of CD29+/CD44+ cell subpopulation were observed, in 
comparison to 3D-M7 cells. However, 3D-TS10 cells despite showing an upregulation of CDH1, 
E-cadherin cytoplasmic staining suggested E-cadherin function impairment. Concerning 3D-TS14 
cells, Vim was downregulated and a heterogeneous E-cadherin staining was observed, with 
expression detected both at cell membrane and in the cytoplasm, suggesting a partial recovery 
of E-cadherin function. Therefore, our findings suggest that EMT reversion was stronger in 3D-
TS14 cells than in 3D-TS10 cells. 
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CHAPTER V 
Discussion 
The occurrence of the EMT/MET phenomenon in cancer progression and metastasis 
development remains rather controversial among the scientific and medical communities, 
despite of the snowball of evidences that have been reported linking the EMT/MET events to 
the depicted situations, both in vitro and in vivo. All the studies that have been performed to 
address this issue have revealed important information about fundamental mechanisms 
underlying the EMT/MET programs. However, a gap between their outcomes and the 
pathological in vivo situation unveiled the need for novel models that would better resemble 
clinical scenarios, in a fine balance of environmental simplicity and complexity. 
In this Master Thesis, we focused on the establishment of a 3D model of EMT/MET in vitro. Such 
model could be further developed in order to generate data concerning novel EMT/MET-related 
targets with relevance in clinics. To establish our 3D in vitro EMT/MET model, we made use of a 
near-normal mouse mammary epithelial cell line (EpH4) that was previously used to establish a 
2D in vitro EMT/MET model induced by TGF-β1 in our research group. Here, we also used TGF-
β1 as trigger for the EMT induction in our 3D model since it has been extensively reported as a 
major inducer of EMT in in vitro and in vivo studies, but also due to its relevance in the clinical 
situation, as described in chapter II of this Thesis. TGF-β1 mediates diverse cellular responses, 
from amongst which cell proliferation suppression176, disruption of cell-cell junctions177 and 
cytoskeleton rearrangements178. To yield a 3D environment for this model, we have resorted to 
an alginate-based hydrogel covalently modified with the adhesion peptide RGD. Alginate 
polysaccharides are obtained from brown seaweed, therefore gathering important features of 
naturally derived-materials, such as biocompatibility and low toxicity. In addition, alginate lacks 
some of the most problematic characteristics of such materials – high variability and unknown 
composition – since commercially available alginates are nowadays well-defined and of ultra-
pure grade. In fact, ultra-pure alginate are submitted to strict purification processes in order to 
remove heavy metals, endotoxins, proteins and polyphenolic compounds that are often present 
in the raw materials179. Alginate provides an ideal blank slate polymer to study specific cellular 
interactions with peptide ligands, such as the one studied in this project, once its hydrophilic 
nature impairs protein adsorption therefore hindering unspecific interactions with mammalian 
cells165. To simultaneously counteract this non-adhesive property of the material and regulate 
cell-substrate interaction, alginate was modified with RGD, a peptide derived from fibronectin 
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that is recognized by many integrins, such as α5β1, α8β1, αIIbβ3, αVβ3, αVβ5, αVβ6 and αVβ8180. 
The concentration of this peptide is an important factor to be considered and it highly depends 
on the cell type used. Since no reports were found addressing the use of RGD in 3D systems for 
EpH4 cells, we adopted a final 200µM concentration of RGD that was used in studies previously 
performed in the group, although for other types of cells108. Preliminary studies of EpH4 cell 
culture in 200µM RGD-alginate hydrogels showed high cell survival and metabolic activity (data 
not shown), therefore we assumed this concentration for the following experiments. RGD-
modified alginate was ionic crosslinked via calcium ions allowing the formation of hydrogels 
under mild and cytocompatible conditions. This process is reversible, allowing easy cell recovery 
in the presence of a calcium chelator. These features are especially relevant allowing the 
development of 3D embedded cultures and enabling cell retrieval after the experiment. Multiple 
studies have proved that cells cultured within 3D matrices form different integrin complexes 
when compared to 2D cultures154, rapidly remodelling their microenvironment and depositing 
their own ECM molecules93. These modifications may trigger important consequences regarding 
cell adhesion and decision-making that can be translated, for instance, into a higher resistance 
to drugs and radiation better mimicking, for example, solid tumours and tumour nodules154,179. 
Matrix mechanics is one of the most relevant features of 3D systems as it modulates cell 
responses in different ways181, albeit it is dynamically changed accordingly to cell density and 
time of culture-dependent matrix deposition182. In the particular case of hydrogels, stiffness 
modifications may also affect oxygen and nutrient permeability, as well as binding sites 
availability and water content183. Therefore, we investigated the possibility of using 1 and 2 wt-
% alginate matrices (G’≈500 and 3500Pa, respectively) and cell densities of 5x106 and 10x106 
cells/mL for our 3D EMT/MET model and evaluated EpH4 cellular responses to these culture 
conditions after 14 days in culture. The obtained results (Figure 9) demonstrated the impact of 
matrix stiffness in spheroid formation and cell viability through the different extents of spheroid 
size and live/dead cells that were observed. In accordance with such results, the softer matrix 
with lower cell density – 1 wt-% alginate matrix with 5x106 cells/mL – allowed the formation of 
much larger spheroids in which almost all cells were viable. These results correlate with other 
studies that showed that in softer matrices of MMP-degradable PEG, significantly larger spheres 
could be obtained through a persistent cellular growth during the first 8 days of culture118. It is 
worth noting that, in our study, seeding a higher cell density in soft matrices resulted in cell 
escape to the periphery of the hydrogel and production of spheroids with smaller size. These 
evidences may reveal that a higher cell density can induce spatial limitation or that cell 
proliferation led to disk outgrowth. An important complement to this study would be the 
measurement of the stiffness of these matrices upon cell culture in each condition. Thus we 
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would be able to understand the effect of EpH4 cells in the matrix and not only the reverse 
influence. Additionally, this study could be of use to compare the ability of epithelial cells, EMT-
derived cells, and MET-derived cells to modulate the surrounding microenvironment. The 
stiffness of the cells themselves, is also an important factor and indeed it was already correlated 
with the occurrence of EMT, when Wu and colleagues demonstrated that cells that underwent 
TGF-β1-induced EMT have higher compressive and tensile stiffness as well as increased adhesion 
force184. Therefore similar studies should also be performed in our different cell types. 
Making use of the 1 wt-% alginate matrix with 5x106 cells/mL we addressed another important 
issue, which is the definition of the TGF-β1 concentration needed for EMT implementation. 
Throughout the different studies in which EMT was induced, different concentrations of TGF-β1 
have been used accordingly to the cell type, culture system (2D vs 3D) and period of induction. 
The only model reported in the literature in which EMT was induced in EpH4 cells was the 
previously 2D model established in our group, for which 8 ng/mL of TGF-β1 were used to induce 
EMT during 7 days of culture55. Other groups were able to establish a stable and irreversible EMT 
model by transforming EpH4 cell line with oncogenic H-Ras (EpRas), and supplementing their 
culture with 8 ng/mL of TGF-β1 during 24 hours145 or 5 ng/mL during 72hours172; in another 
study, TGF-β1 supplementation (2.5 ng/mL) was complemented with 4-hydroxytamoxifen for 
Raf activation and EMT was analysed upon 6 days of treatment173. We attempted to induce EMT 
in the 3D system using 8 ng/mL of TGF-β1 as previously done in the 2D system, however even 
upon 14 days in culture – with the supplemented culture medium being renewed every 2-3 days 
– we could not observe a consistent EMT phenotype (Figure 26D-26F). Most likely, the 3D 
environment and proportion of cells for the available amount of TGF-β1 conditioned its activity, 
which explains why we were only able to observe minimal expression of Fibronectin and no 
delocalization of E-cadherin (Figure 26D-26F). By doubling the concentration of TGF-β1, we 
overcame that limitation which was demonstrated through the production of higher amounts 
of Fibronectin and lower expression of E-cadherin (Figure 26G-26I).  
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Figure 26. Evaluation of the TGF-β1 potential to induce EMT in the 3D in vitro system. Co-
immunofluorescence for E-cadherin (red) and Fibronectin (green) in 3D-E14 cells (A-C) and 3D-M14 
obtained with 8ng/mL (D-F) or 16ng/mL (G-I) of TGF-β1. Merged images (C, F, I) illustrate the loss of E-
cadherin at cell membrane and the expression of de novo-Fibronectin in 3D-M14 cells derived from the 
exposure to 16 ng/mL of TGF-β1. The scale bar corresponds to 50µm. 
 
Interestingly, we found that both in the presence and absence of TGF-β1, EpH4 cells tend to 
form spheroids with different 3D architecture and in some cases they form lumenized structures 
(Figure 27)91. In fact, EpH4 cells had already prove their ability to form acini-like185 and branched 
organ-like structures186 in Matrigel and 3D collagen gel, respectively. Further studies are needed 
in order to characterize the functionality and organization of the lumenized structures obtained 
in our model, thus enabling the comparison with the acini-like structures derived from other 
natural matrices185,186. The possibility of studying these structures in a more controllable and 
defined, yet biologically relevant system, such as ours, may be translated into important insights 
in normal breast development and ultimately breast cancer progression.  
A. B. C. 
D. E. F. 
G. H. I. 
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Figure 27. Architecture of the lumenized spheroids found both in the 3D epithelial and EMT-derived 
cultures. Representation of structures found at day 14, 3D-E14 and 3D-M14, at different Z Stacks. The size 
of the structures is not representative from each culture. Cell nuclei is stained with DAPI (blue). The scale 
bar corresponds to 50µm. 
 
In order to optimize and further validate the TGF-β1-driven EMT model, we characterized the 
cellular behaviour of both epithelial and mesenchymal cultures in the 3D matrix. We observed 
a stable epithelial phenotype during the first 14 days of culture, and the establishment of EMT 
after 7 days of culture (3D-M7), characterized by E-cadherin delocalization to the cytoplasm 
(Figure 16 and Figure 23B), upregulation of CDH2, Vim, ZEB2 and Twist1 (Figure 18). 
Interestingly, 3D-M14 cells displayed similar features, although their metabolic activity was 
much lower (Figure 15). We measured the metabolic activity using the classic resazurin assay, in 
which this redox dye is reduced within the mitochondria by accepting the electrons resulting 
from the normal mitochondrial enzymatic activity187. Therefore, the observed decrease may be 
due to a metabolic shift that was also found in the 2D in vitro model (unpublished data). In fact, 
2D-M7 cells displayed protein expression downregulation of several oxidative phosphorylation 
components with a concomitant increased level of lactate production. Given that resazurin was 
already proved to be a reliable method for identification of mitochondrial functional defects188, 
we believe that the metabolic shift observed in the 2D EMT model may also be occurring in our 
3D model. The observed decrease of metabolic activity may also be due to other features, such 
as reduced cell growth, which has already been associated with TGF-β1 treatment25. To elucidate 
the basis of this metabolic decrease, further studies should be performed, for instance, 
measurement of lactate production and glycose consumption together with the determination 
of growth rates in the 3D cultures.  
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Another function of TGF-β1 is the modulation of the balance of MMPs and their inhibitors, 
mainly the tissue inhibitors of MMPs (TIMPs) and the membrane-associated MMP inhibitor 
(RECK), thus modulating the cell motility and invasion29,189. Enhanced MMP activity has been 
correlated with cell migration and invasion of carcinoma cells, and it has been reported in a wide 
range of carcinomas such as colon, prostate, breast and ovarian carcinomas190. Therefore, an 
enhanced ability to produce MMP9/MMP2 would be expected in 3D-M cells compared to the 
epithelial control, as already observed in the 2D model (Figure 8). However, in our 3D in vitro 
conditions, no difference was found regarding the production of MMPs between epithelial cells 
and EMT-derived cells (Figure 17). This may be due to the short period of time (24h) in which 
the conditioned media used was exposed to cells. Therefore, by increasing this period of time 
(48h), our MMP evaluation methodology could be optimized, as we show for 3DE14 and 3DM14 
cells (Figure 28). In addition, other techniques are available that may more accurately assess 
MMPs secretion and activity. For example, we could translate our 3D model into proteolytically 
degradable MMP-sensitive alginate hydrogels, and follow their degradation, by MMPs, using 
Safranin-O/light-green staining112. This method differs from the zymography given that we could 
observe, in real time, MMP activity, bypassing all the technical methodology associated with 
zymography. 
 
Figure 28. MMP2 and MMP9 secretion for 3D-E14 and 3D-M14 cells. Relative quantification was 
performed to normal culture medium (CM). 16ug of total protein were loaded for each sample (n=2 
biological replicas). Conditioned media with 48h of culture was collected. 
 
Our characterization of the TGF-β1-induced EMT in the 3D in vitro system, showed that both 
3D-M7 and 3D-M14 cells displayed a mesenchymal signature (Table 5). However, 3D-M14 cells 
also displayed an unexpected increase in E-cadherin presence at the cell membrane. Moreover, 
a matrix-related effect was observed in the control epithelial culture starting after day 14, 
suggesting that the matrix itself alters these cells. This suggested that 3D-M14 cells may derive 
from a concomitant effect of TGF-β1 and the matrix itself. Therefore we selected 3D-M7 cells as 
our EMT end-point. 
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Table 5. Summary of the characterization of TGF-β1-induced EMT in the 3D in vitro system 
Criteria 3D-M7 3D-M10 3D-M14 
Gene 
Expression 
CDH1 ++ +++ ++ 
Ocln = --- = 
CDH2 +++ +++ +++ 
Vim + ++ ++ 
ZEB2 +++ ++ +++ 
Twist1 + --- + 
Protein 
Localization 
E-Cadherin Cytoplasm Cytoplasm 
Cytoplasm & Cell 
Membrane 
α-SMA Cytoplasm Cytoplasm Cytoplasm 
Protein 
Expression 
E-Cadherin Low/Absent Medium Medium 
α-SMA Low Medium Medium 
MMP 
production 
MMP9 = = = 
MMP2 = = = 
Metabolic activity = -- -- 
Legend of symbols: (---) <0.33-fold; (--) 0.33-0.50-fold; (-) 0.50-0.67-fold; (=) 0.67-1.50-fold; (+) 1.50-2.00-fold; (++) 
2.00-3.00-fold; (+++) >3.00-fold. Data normalized to 3D-E7 cells. 
 
By removing the TGF-β1 stimulus after EMT, i.e. after 7 days of culture, we observed a strong 
reversion from the mesenchymal to an epithelial-like phenotype in the 3D-TS14 cells. This 
phenotype was characterized, when comparing with 3D-M7 cells, by upregulation of Twist1 and 
also of the genes ID2 and ID3, which derived from the characterization of EMT reversion 
previously obtained in the EpH4 EMT/MET 2D model. Moreover, 3D-TS14 cells also exhibited 
downregulation of Vim (Figure 24) and heterogeneity regarding E-cadherin and α-SMA staining 
in the spheroids (Figure 22 and Figure 23B). Additionally, the metabolic activity of 3D-TS14 cells 
increased, which could be due to a higher cell density resulting from a higher proliferation rate 
(Figure 20). In order to address this question, we measured cell protein content, assuming that 
it would mirror cell density. Our results in fact suggested that protein cell content increased 
along with time of culture. However, after normalizing the metabolic activity to those values, 
we found a considerable difference between normalized and non-normalized metabolic rates 
(Figure 20). Despite these differences, in 3D-TS14 cells both non-normalized and normalized 
metabolic rates showed the same trend of recovery to 3D-E14 cells level. The main differences 
were observed in 3D-E7 to 3D-E10 and 3D-TS10 to 3D-TS14: both comparisons revealed that, 
after normalization to the protein content, 3D-E10 and 3D-TS14 displayed a halt in metabolic 
activity, which could be associated with high cell density. Additional studies to understand the 
basis of these metabolic changes are needed, such as live/dead assays as well counting the 
number of cells present at each time-point in each disk. 
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Regarding the MMP production, the increased secretion found in 3D-TS10 and 3D-TS14 (Figure 
21) revealed a completely different behaviour from what was observed in the 2D in vitro system: 
2D-M7 cells developed a higher ability to produce MMP9, while 2D-TS11 cells lost such feature 
(Figure 8). The inconsistencies found in the assessment of MMPs production in the 3D system 
were in fact similar to those previously discussed, reinforcing the need for either methodology 
optimization or implementation of novel technical strategies. 
Due to the heterogeneity found within each population (2D/3D-E, M and TS cells), we attempted 
to find differences in the expression of surface markers that could help us analyse the stem-cell 
potential of these cells. We assessed the markers CD29 (integrin-β1) and CD44 due to their 
previous association with EMT and CSCs72. In fact, several works reported CD44 and CD29 as cell 
surface markers used to isolate CSC191. Additionally, breast cancer CSCs have been distinguished 
from cells lacking tumour initiating ability via CD29hi/CD44med markers69, and CD29hi/CD44hi cells 
in squamous cell carcinoma have been associated with enriched CSC and EMT features72. In line 
with these studies, we observed a significant increase of the CD29+/CD44+ subpopulation in the 
2D-M7 cells. However, in the 3D model, the same was not observed. Concerning the EMT 
reversion, the CD29+/CD44+ subpopulation was decreased in 2D-TS11 cells as well as in 3D-TS10 
and 3D-TS14 cells (Figure 7A and Figure 23A). This common downregulation of the stem-cell like 
subpopulation in 2D/3D-TS cells narrows the gap between the two models. Nevertheless, more 
experiments should be performed using the 3D model, to confirm this hypothesis, such as 
testing other combinations of known EMT/CSC markers such as CD44+/CD24- 69–71. 
Summing up, the characterization of the TGF-β1-induced EMT/MET in the 3D in vitro system 
showed that 3D-TS14 cells displayed a partial EMT reversion (Table 6). This metastable 
phenotype is associated with a concomitant expression of α-SMA and membrane-located E-
cadherin. Therefore, our model could be used to study transient phenotypes occurring during 
the metastatic process, enabling the monitoring of cellular interactions in a complex 3D 
environment. Indeed, the EpH4 EMT/MET 2D in vitro model previously established in our 
research group, also demonstrated the occurrence of a MET-derived metastable phenotype, in 
which different cell subpopulations were found (unpublished data). Further studies will be 
needed to understand if our 3D EMT/MET-derived cultures also display such distinct 
subpopulations. If those heterogeneous populations are indeed present in our 3D model, novel 
experiments addressing the cooperation between non-EMT and EMT cells, as well as the 
occurrence of diverse cycles of EMT/MET during cancer progression and metastasis, could be 
designed. 
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Table 6. Summary of the characterization of TGF-β1-induced EMT/MET in the 3D in vitro system 
Criteria 3D-M7 3D-TS10 3D-TS14 
Gene 
Expression 
CDH1 = = + 
Ocln = = = 
CDH2 ++ ++ ++ 
Vim +++ +++ ++ 
ZEB2 +++ = ++ 
Twist1 = = ++ 
Mgat3 -- --- -- 
ID2 -- = -- 
ID3 = - = 
Protein 
Localization 
E-Cadherin Cytoplasm Cytoplasm 
Cytoplasm & Cell 
Membrane 
α-SMA Cytoplasm Cytoplasm Cytoplasm 
Protein 
Expression 
E-Cadherin Residual Low Medium 
α-SMA Low Residual Low 
MMP 
production 
MMP9 = = = 
MMP2 = = + 
Metabolic activity = +++ = 
Cellular 
Populations 
CD29+ = = = 
CD44+ = - = 
CD29+/CD44+ = = = 
Legend of symbols: (---) <0.33-fold; (--) 0.33-0.50-fold; (-) 0.50-0.67-fold; (=) 0.67-1.50-fold; (+) 1.50-2.00-fold; (++) 
2.00-3.00-fold; (+++) >3.00-fold. Data normalized to 3D-E7 cells. 
 
Alongside to the TGF-β1-induced EMT/MET model, we monitored the behaviour of the EpH4 
epithelial cells in the 3D in vitro system for longer periods of culture. Interestingly, we observed 
that 3D-E17 cells displayed increased expression of the mesenchymal marker α-SMA (Figure 11), 
upregulation of CDH2, Vim, ZEB2, as well as decreased expression of CDH1 (Figure 13). Together, 
these findings suggest that the 3D environment may be inducing the EpH4 cells to undergo a 
transient EMT. Possibly, the increased cellular density and eventual ECM deposition may induce 
an overall increase of stiffness that in turn triggers EMT, as previously discussed. Additionally, 
this mesenchymal signature was abrogated in 3D-E21 cells, indicating that a cyclic EMT induction 
modulated by the 3D environment may be occurring. Again, if true, this hypothesis would be of 
great interest to gain important insights regarding the cycles of EMT/MET during cancer 
progression and metastasis. 
Our 3D in vitro EMT/MET model driven by TGF-β1 (Figure 29) emphasizes interesting features of 
both processes that are associated to important findings arising from in vivo studies. However, 
the work developed in this Master Thesis constitutes a preliminary data set that requires further 
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validation experiments, given that most of our results derived from a single biological replica. 
Nevertheless, the results obtained during this short approach encourage the application of this 
3D system for the study of EMT/MET. Our results reveal the potential of this model to unravel 
novel mechanisms, biomarkers, and ultimately therapies associated with EMT/MET in the scope 
of cancer progression and metastasis establishment. Furthermore, our model may be useful to 
elucidate the origin of the high resistance to chemotherapy and radiotherapy in EMT-derived 
cells, which was not observed in MET-derived cells83. Such studies could help answer some 
questions that remain open: should subclinical tumours be induced to undergo MET to facilitate 
therapy? Can new biomarkers for EMT be useful to better understand cancer progression? Is 
MET stable in metastasis or secondary EMT may also occur? We believe that our 3D model and 
our ability to create EMT-cells and metastable-like cells could be a useful tool to answer such 
questions. 
 
 
Figure 29. Global representation of the 3D in vitro TGF-β1 induced EMT/MET model in RDG-modified 
hydrogels. A. Appearance of a RGD-modified hydrogel, such as the ones used for the 3D cell culture. B. 
Alginate crosslinking via calcium ions. The resulting network allows the free diffusion of TGF-β1 molecules 
across the hydrogel. C. In the presence of TGF-β1 for 7 days, TGF-β1 signaling pathways lead to 
delocalization of E-cadherin to the cytoplasm and expression of α-SMA, as a result of the implementation 
of a transcriptional EMT program based in the upregulation of CDH2, Vim, ZEB2 and Twist1. D. 7 days 
upon removal of the TGF-β1 stimulus and consequent signalling pathways, E-cadherin undergoes 
translocation to cell membrane and α-SMA is decreased due to the implementation of a MET program in 
which Twist1, ID2 and ID3 are upregulated while Vim is downregulated. 
A. 
B. 
C. D. 
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CHAPTER VI 
Conclusions 
The overall gap found between the outcomes of traditional 2D cancer models and its clinical 
success nourished the concretization of this Thesis, in which we aimed to establish a 3D in vitro 
model for EMT/MET induction. 
First, we focused on complementing the 2D in vitro model of TGF-β1-mediated EMT/MET 
induction by addressing the expression of EMT and CSC-related molecules and the secretion of 
MMPs by EMT and MET-derived cells. This study revealed that EMT-derived cells present 
stemness features as well as increased ability to degrade the basement membrane and the ECM 
in comparison to EpH4 epithelial and MET-derived cells. 
Secondly, we initiated the development of the 3D in vitro TGF-β1-driven EMT/MET system by 
culturing the EpH4 cell line within RGD-modified alginate hydrogels. We concluded that softer 
matrices with low cellular density allow the formation of large spheroid with different 
architectures that express classical epithelial markers, i.e. E-cadherin, in the absence of TGF-β1 
supplementation. Additionally, we concluded that our 3D system can be used for epithelial 
culture of EpH4 cell line without significant phenotypic variations during the first 14 days of 
culture, which might be particularly interesting to study the epithelial morphogenesis and 
potentially the function of normal mammary gland. Moreover, the extension of the culture of 
these cells to 17 days showed the induction of an EMT-like program with upregulation of 
mesenchymal markers and downregulation of epithelial markers. This EMT program seems to 
be transient and probably resulting from cell-matrix interactions. 
Using this 3D system, we observed that EMT can be achieved via TGF-β1 treatment, with E-
cadherin delocalization to the cell cytoplasm, presence of α-SMA and upregulation of several 
EMT-related genes. 
Thereafter, to complete the establishment of the EMT/MET model, we monitored the cellular 
behaviour of EMT-derived cells for 7 days in 3D culture without TGF-β1 supplementation. Our 
results showed a concomitant upregulation of Twist1, ID2 and ID3, downregulation of Vim, 
increased E-cadherin expression with maintenance of α-SMA expression, and decreased stem-
cell like subpopulation, suggesting the occurrence of a partial MET program. 
In conclusion, we were able to translate a previously established 2D model of EMT/MET to a 
novel 3D in vitro system using TGF-β1 treatment. The main strength of this work was the 
identification of viable readouts of this 3D system, which enable its manipulation in the future, 
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by altering, for example, the matrix components. Following the insights described in this Thesis, 
a robust high-throughput and novel system can be established for further studies on cancer 
progression and metastasis formation. 
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CHAPTER VII 
Future Perspectives 
One of the major drawbacks of the work developed in this Master Thesis is that most results 
derive from a single biological replicate. Therefore, the first task that should be performed to 
better strengthen this project, is to reproduce all the experiments previously described. 
 
In particular, as suggested in Chapter V, a clearer definition of metabolic states and 
growth/proliferation rates of the different cell populations should be addressed. In addition, 
activity of MMPs and stiffness measurements would also be of great importance to confirm 
some of the uncertainties identified during this Thesis.  
 
The activity of MMPs could also be complemented with the design of migration/invasion studies 
that would ultimately show the efficiency of these cells in degrading the ECM and the basement 
membrane. Thereafter, matrix variations at chemical (composition) and physical (mechanics 
mesh size) levels could be introduced in order to investigate how cell in the different stages of 
the EMT/MET process would react and adapt to these environmental changes. For this purpose, 
the readouts defined in this Thesis will be crucial to rapidly and efficiently spot the phenotypic 
responses to those changes. 
 
Due to the high levels of stress that cells may undergo when transferred from a 2D culture to a 
3D environment, another interesting study would be the induction of EMT only after spheroid 
formation with cells already presenting a stable epithelial phenotype.  
 
Analogous studies should be performed to evaluate the potential matrix-driven EMT induction 
that was observed in prolonged cultures of EpH4 cells, taking into account the biological 
relevance that this phenomenon may have in the process of understanding the crosstalk 
between EMT/non-EMT cells and the surrounding environment.  
 
Our 3D EMT/MET in vitro TGF-β1 model would also benefit from a parallel study using other cell 
lines, such as a human derived cell lines. Having in mind a potential clinical usage of our model, 
for instance drug screening, it would be of outmost interest to test the potential of primary 
cultures in this system. If successful, this approach might indicate the possibility of culture 
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biopsies from patient’s tumours, allowing a personalized therapy and perhaps help in the 
prognostic decision-making. 
 
Finally, the characterization of the organized and lumenized structures formed by EpH4 could 
become an additional focus of this project, since it can be translated into a novel 3D complex 
system to study the normal mammary gland, and perchance the tumorigenic process in this cells. 
 
In summary, our 3D in vitro EMT/MET model exhibits a myriad of potential applications in cancer 
research that are worth to pursue in future research projects. 
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